DIARYLPYRAZOLE COMPOUND AND FORMULATION TO CONTROL HARMFUL ORGANISMS

Abstract

A compound represented by formula (1) or a salt thereof, as well as a formulation for controlling harmful organisms, and in particular, an insecticidal formulation, a miticide formulation, a formulation for controlling ectoparasites, or a formulation for controlling or exterminating endoparasites, which contains at least one compound selected from the compounds of formula (1) and salts thereof as an active ingredient; wherein each of R 1 and R 2 independently represents a hydrogen atom, an alkyl group C 1-6 replaced or not replaced, or similar, on the condition that when R 2 represent a hydrogen atom, R 1 represent an aryl group C 6-10 substituted or unsubstituted or a substituted or unsubstituted 3- to 6-membered heterocyclyl group; R 3 represents an al-quiltium group C 1-6 or similar; each of R 4 and R 5independently represents a hydrogen atom, a halogen or similar group; Ar represents an aryl group C 6-10 substituted or not substituted, or a substituted or not substituted 5- to 6-membered heteroaryl group.

Description

NATIONAL INSTITUTE OF INDUSTRIAL PROPERTY NATIONAL PATENT ADMINISTRATION APPLICATION FOR A PATENT OF INVENTION ARAGISH REPUBLIC UTILITY MODEL APPLICATION Sheet of I. APPLICANT(S) NUMBER OF APPLICANTS NIPPON SODA CO. LTD. CUIT / CUIL / CDI: > Enter Name and Surname or Company Name (of one of them, the rest in ANNEX) ID card Individuals: Marital status: Nuptials Spouse's name and surname: ID card 2-1, OHTEMACHI 2-CHOME, CHIYODA-KU Real Address: Street: No.; Floor and Apt. Locality: TOKYO CP No. 100-8165 Country of Residence: JP Av. DEL LIBERTADOR 5936 / 54 FLOOR 7 AUTONOMOUS CITY OF BUENOS AIRES C1428 ARP PomicilloTegal / - CaljéSN0 - LocaliclSd;- Provinces =· Email address: patents@moellerip.com Phone: Zip code 4788-7777 II. OBJECT .' ... · Title of the invention: DIARYLPYRAZOLE COMPOUND AND FORMULATION FOR CONTROLLING HARMFUL ORGANISMS Nature of the Patent / Utility Model INDEPENDENT Patent No. In addition to: Application No. Divisional of Application No. PRIORITY (LAW 17.011) COUNTRY NUMBER DATE -- INPI CONTf i Ndulonai de l IOL ADJUL«.in lentes 1 I INTIMACK y □sf J MICROORGANISM DEPOSIT DEPOSIT DATE DEPOT ACCESS NUMBER Name of the Depository Institution Institution's Address 'Country Depositor Details Origin of Biological and Genetic Material Continued on attached sheet: III. SOCIETIES COMPANY REPRESENTED BY GERARDO MESSERER AND / OR MOELLER & CO SA WHO DECLARES UNDER OATH THAT HE HOLDS THE CHARACTER OF PROXY THAT HIS THE MANDATE IS IN FORCE AND THE COMPANY IS REGISTERED IN Registration details in RPC / IGJ Date: Number Folio No. Took: IV. MANDATE Power of attorney registered with the INPI under number: 1,616 and 25,000 IN THIS ACT, THE FOLLOWING IS AUTHORIZED: (Surname and First Name and ID Number] For all those purely procedural tasks such as making breakdowns, withdrawing testimonies, certificates, titles, copies and notifications in the file. Responding to hearings, withdrawing applications, making requests (only when the Authorized Party is an Industrial Property Agent) POWER OF ATTORNEY IS ENCLOSED AGENT NO. 734 I NO V. PRIOR DISCLOSURE STATEMENT For the purposes of Article 5 of Law 24.481, it is hereby stated that the present invention has been previously disclosed: [No. I (YES / NO) If yes, on the date: | | VI. OBSERVATIONS ATTACHED: ORIGINAL TEXT IN ENGLISH ON CD-ROM Please note that the information provided in this form constitutes a sworn statement; any falsehood contained herein will have the corresponding legal consequences. NOTE: Payment of the corresponding fee must be made at the time of submission or during the first two hours of business on the following business day. Failure to make payment within this period will automatically result in the submission being considered not made and having no effect. Signature of the authorized person(s): MOELLER Co. SA __________________LIDIA KEl FEILER______________ Signature of the applicant or their legal representative INTERNAL USE ONLY - THE PRESENTATION CONSISTS OF |__________ PAGES CHANGE OF ADDRESS / EMAIL / TELEPHONE: DATE '«< i*·.. ...... Address No. Locality: | | Postal Code No. | | Country of Residence: | «« Legal Address - Street - No. - Locality - Province Postal Code ' Email Address: | | Telephone: CHANGE OF ATTORNEY / AUTHORIZED: DATE New Attorney or Authorized: | TRANSFER OR CHANGE OF BUSINESS ACTIVITY: | P-115.845 / sbh DESCRIPTIVE MEMORANDUM DELA PATENT OF INVENTION for the term of TWENTY YEARS on: DIARYLPYRAZOLE COMPOUND AND FORMULATION TO CONTROL HARMFUL ORGANISMS requested by: NIPPON SODA CO., LTD. TOKYO JAPAN DESCRIPTIVE MEMORANDUM TECHNICAL FIELD The present invention relates to a diarylpyrazole compound and a formulation for controlling harmful organisms. Specifically, the present invention relates to a diarylpyrazole compound that has superior insecticidal and / or acaricidal activity, exhibits greater safety, and can be advantageously synthesized industrially, and further relates to a formulation for controlling harmful organisms that contains said compound as an active ingredient. BACKGROUND Several compounds with insecticidal and / or acaricidal activity have been proposed. For these compounds to be used practically as agrochemicals, they must not only be sufficiently effective, but also have minimal chemical resistance, avoid phytotoxicity to plants or soil contamination, and have low toxicity to cattle, fish, or similar animals. Patent Document 1 describes a compound represented by Formula (a). Patent Document 1 describes that the aforementioned compound has insecticidal and / or acaricidal activity. Patent Document 2 describes a compound represented by Formula (b). Patent Document 2 describes that the aforementioned compound has insecticidal and / or acaricidal activity. (b) Patent Document 3 describes a compound represented by Formula (c). Patent Document 3 describes that the aforementioned compound has insecticidal and / or acaricidal activity. BIBLIOGRAPHY OF THE PREVIOUS TECHNIQUE Patent Documents PCT International Publication No. W02010 / 136145 PCT International Publication No. WO2016 / 113155 PCT International Publication No. W02016 / 204270 DESCRIPTION OF THE INVENTION Technical Problem An objective of the present invention is to provide a diarylpyrazole compound that has superior activity for controlling harmful organisms, and in particular, superior insecticidal and / or acaricidal activity, exhibits superior safety, and can be industrially and advantageously synthesized; and also to provide a formulation for controlling harmful organisms containing said compound as an active ingredient. Additionally, a further objective of the invention is to provide a formulation for controlling ectoparasites or a formulation for controlling or expelling endoparasites containing said compound as an active ingredient. Solution to the Problem As a result of thorough studies to achieve the aforementioned objectives, the inventors of the present application completed the present invention including the following features. [1] A compound represented by Formula (I) or a salt thereof. R3 wherein each of R1 and R2 independently represents a hydrogen atom, a substituted or unsubstituted Cl-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a hydroxyl group, a substituted or unsubstituted Cl-6 alkoxy group, a formyl group, a substituted or unsubstituted Cl-6 alkylcarbonyl group, a substituted or unsubstituted Cl-6 alkoxycarbonyl group, a mercapto group, a substituted or unsubstituted Cl-6 alkylthio group, a substituted or unsubstituted Cl-6 alkylsulfinyl group, a substituted or unsubstituted Cl-6 alkylsulfonyl group, a substituted or unsubstituted aminocarbonyl group, a substituted or unsubstituted C3-8 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted C6-10 aryloxy group unsubstituted, a substituted or unsubstituted 3- to 6-membered heterocyclyl group, a substituted or unsubstituted amino group, a halogen group, a cyano group, or a nitro group,provided that if R2 is a hydrogen atom, R1 is a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 3- to 6-membered heterocyclyl group, R3 represents a substituted or unsubstituted Cl-6 alkylthio group, a substituted or unsubstituted Cl-6 alkylsulfinyl group, a substituted or unsubstituted Cl-6 alkylsulfonyl group, a substituted or unsubstituted Cl-6 alkylsulfonyloxy group, or a group represented by -S(=O)(=N-Ra)-Rb, wherein each of Ra and Rb independently represents a substituted or unsubstituted Cl-6 alkyl group, each of R4 and R5 independently represents a hydrogen atom, a halogen group, a cyano group, a substituted or unsubstituted Cl-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a hydroxyl group, a substituted or unsubstituted Cl-6 alkoxy group, a formyl group, a substituted or unsubstituted Cl-6 alkylcarbonyl group, or a substituted or unsubstituted alkoxycarbonyl group Cl-6, a substituted or unsubstituted alkylthio group Cl-6, a substituted or unsubstituted alkylsulfinyl group Cl-6,a substituted or unsubstituted Cl-6 alkylsulfonyl group, a substituted or unsubstituted Cl-6 alkylsulfonyloxy group, a substituted or unsubstituted amino group, or a group represented by -S(=O)(=N-Ra)-Rb, wherein each of Ra and Rb independently represents a substituted or unsubstituted Cl-6 alkyl group, and, Ar represents a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heteroaryl group. [2] The compound according to [1] mentioned above or a salt thereof, wherein R1 represents a hydrogen atom, R2 represents a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 3- to 6-membered heterocyclyl group, R3 represents a Cl-6 alkylsulfonyl group, R4 represents a Cl-6 alkyl group, or a substituted or unsubstituted amino group, and R5 represents a hydrogen atom. [3] The compound according to [1] mentioned above or a salt thereof, wherein R1 represents a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 3- to 6-membered heterocyclyl group, R2 represents a hydrogen atom, R3 represents a Cl-6 alkylsulfonyl group, R4 represents a Cl-6 alkyl group, or a substituted or unsubstituted amino group, and R5 represents a hydrogen atom. [4] A formulation for controlling harmful organisms, containing at least one compound selected from the group consisting of the compounds as mentioned in any of [1] to [3] above and salts thereof, as an active ingredient. [5] An insecticidal formulation or an acaricidal formulation, containing at least one compound selected from the group consisting of the compounds as mentioned in any of [1] to [3] above and salts thereof, as an active ingredient. [6] A formulation for controlling ectoparasites, containing at least one compound selected from the group consisting of the compounds as mentioned in any of [1] to [3] above and salts thereof, as an active ingredient. [7] A formulation for controlling or expelling endoparasites, containing at least one compound selected from the group consisting of the compounds as mentioned in any of [1] to [3] above and salts thereof, as an active ingredient. Advantageous Effects of the Invention The diarylpyrazole compounds of the present invention can control harmful organisms that are problematic for agricultural products or hygiene. In particular, the compounds can effectively control various types of agricultural pests and mites at low concentrations. Additionally, the diarylpyrazole compounds of the present invention can effectively control ectoparasites and endoparasites that are harmful to humans and animals. IMPLEMENTATIONS OF THE INVENTION Diarylpyrazole compounds A diarylpyrazole compound of the present invention is a compound represented by Formula (I) (hereinafter referred to as compound (I) in some cases) or a salt of compound (I). R3 (YO) In the present invention, the term “unsubstituted” means that only one group, which is a parent nucleus, is present. When only the name of a group is described as a parent nucleus without the term “substituted,” it means “unsubstituted” unless otherwise specified. On the other hand, the term “substituted (= having a substituent)” means that at least one hydrogen atom of a parent group is replaced with a group that has the same or a different structure than the parent group. Therefore, a “substituted group (substituent)” is another group that is bonded to the parent group. There can be one, two, or more substituted groups. Two or more substituted groups can be the same or different from each other. The term “Cl-6” represents the number of carbon atoms in a group as a parent nucleus, ranging from 1 to 6. The number of carbon atoms does not include the number of carbon atoms present in a substituted group. For example, a butyl group that has an ethoxy group as a substituted group is classified as a C2 alkyl alkoxy group. A “substituted group” is not particularly limited as long as it is chemically acceptable and has the effect of the present invention. Examples of a group that may be a “substituted group” include an alkyl group (Cl-6) such as a methyl group, an ethyl group, an n-propyl group, an i-propyl group, an n-butyl group, an s-butyl group, an i-butyl group, a t-butyl group, an n-pentyl group, or an n-hexyl group. a C2-6 alkenyl group such as a vinyl group, a 1-propendo group, a 2-propenyl group (an allyl group), a 1-butenyl group, a 2-butenyl group, a group 3-butenyl, a 1-methyl-2-propenyl group, or a 2-methyl-2-propenyl group; a C2-6 alkynyl group such as an ethynyl group, a 1-propynyl group, a 2-propynyl group, a 1-butynyl group, a 2-butynyl group, a 3-butynyl group, or a / group 1 -methyl-2-propynyl; a C3-8 cycloalkyl group such as a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, or a cuband group; a C6-10 ardo group such as a phenyl group, or a naphthyl group; an aryl C6-10 alkyl Cl-6 group such as a benzyl group, or a phenethyl group; a heterocyclic group of 3 to 6 members; a 3- to 6-membered Cl-6 heterocyclyl-alkyl group; a hydroxyl group; a Cl-6 alkoxy group such as a methoxy group, an ethoxy group, an n-propoxy group, an i-propoxy group, an n-butoxy group, an s-butoxy group, an i-butoxy group, or a t-butoxy group; a C2-6 alkenyloxy group such as a vinyloxy group, an allyloxy group, a propendoxy group, or a butenyloxy group; a C2-6 alkynyloxy group such as an ethinyloxy group, or a propargyloxy group; a C6-10 aryloxy group such as a phenoxy group, or a naphthoxy group; a C6-10 aryl Cl-6 alkoxy group such as a benzyloxy group, or a phenethyloxy group; a 5- to 6-membered heteroaryloxy group such as a thiazolyloxy group, or a pyridyloxy group; a 5- to 6-membered heteroaryl-alkyloxy Cl-6 group such as a thiazolyl methyloxy group, or a pyridylmethyloxy group; a formyl group; an alkyl Cl-6 carbonyl group such as an acetyl group, or a propionyl group; a formyloxy group; an alkyl Cl-6 carbonyloxy group such as an acetyloxy group, or a propionyloxy group; a C6-10 aryl carbonyl group such as a benzoyl group; an alkoxy Cl-6 carbonyl group such as a methoxycarbonyl group, an ethoxycarbonyl group, an n-propoxycarbonyl group, an i-propoxycarbonyl group, an n-butoxycarbonyl group, or a t-butoxycarbonyl group; a Cl-6 alkoxy carbonyloxy group such as a methoxycarbonyloxy group, an ethoxycarbonyloxy group, an n-propoxycarbonyloxy group, an i-propoxycarbonyloxy group, an n-butoxycarbonyloxy group, or a t-butoxycarbonyloxy group; a carboxyl group; a halogen group such as a fluorine group, a chlorine group, a bromine group, or an iodine group; a Cl-6 haloalkyl group such as a chloromethyl group, a chloroethyl group, a difluoromethyl group, a trifluoromethyl group, a 2,2,2-trifluoroethyl group, a perfluoroethyl group, a 1,2-dichloro-n-propyl group, a 1-fluoro-n-butyl group, or a perfluoro-n-pentyl group; a C2-6 haloalkenyl group such as a 2-chloro-1-propenyl group, or a 2-fluoro-l-butenyl; a C2-6 haloalkynyl group such as a 4,4-dichloro-1-butynyl group, a group 4-fluoro-1-pentynyl, or a 5-bromo-2-pentynyl group; a Cl-6 haloalkoxy group such as a trifluoromethoxy group, a 2-chloro-n-propoxy, or a 2,3-dichlorobutoxy group; a C2-6 haloalkenyloxy group such as a 2-chloropropenyloxy group, or a group 3-bromobutenyloxy; a C1-6 haloalkyl carbonyl group such as a chloroacetyl group, a trifluoroacetyl group, or a trichloroacetyl group; an amino group; an amino group substituted with Cl-6 alkyl such as a methylamino group, a dimethylamino group, or a diethylamino group; a C6-10 aryl amino group such as an anilino group, or a naphthylamino group; an aryl C6-10 alkyl Cl-6 amino group such as a benzylamino group, or a phenethylamino group; a formylamino group; a Cl-6 alkyl carbonylamino group such as an acetylamino group, a propanoylamino group, a butyrylamino group, or an i-propyl carbonyl amino group; a mono(alkoxy Cl-6 carbonyl)amino group such as a methoxycarbonyl amino group, an ethoxycarbonylamino group, an n-propoxycarbonylamino group, an i-propoxycarbonylamino group, or a t-butoxycarbonylamino group; a di(alkoxy Cl-6 carbonyl)amino group such as a di(methoxycarbonyl)amino group, a di(ethoxycarbonyl)amino group, a di(n-propoxycarbonyl)amino group, a di(i-propoxycarbonyl)amino group, a di(n-butoxycarbonyl)amino group, or a di(t-butoxycarbonyl)amino group; a substituted or unsubstituted aminocarbonyl group such as an aminocarbonyl group, a dimethylaminocarbonyl group, a phenylaminocarbonyl group, or an N-phenyl-N-methylaminocarbonyl group; a Cl-6 imino alkyl group such as an iminomethyl group, an (l-imino)ethyl group, or an (l-imino)-n-propyl group; un grupo N-hidroxiiminoalquilo Cl-6 sustituido o un sustituido tal como grupo N-hidroxi-iminometilo, grupo (l-(N-hidroxi)-imino)etilo, grupo (l-(N-hidroxi)-imino)propilo, grupo N-metoxi-iminometilo, o grupo (l-(N-metoxi)-imino)etilo; an aminocarbonyloxy group; an alkyl Cl-6 aminocarbonyloxy group such as an ethylaminocarbonyloxy group, or a dimethylaminocarbonyloxy group; a mercapto group; an alkylthio Cl-6 group such as a methylthio group, an ethylthio group, an n-propylthio group, an i-propylthio group, an n-butylthio group, an i-butylthio group, an s-butylthio group, or a t-butylthio group; a haloalkylthio Cl-6 group such as a trifluoromethylthio group, or a group 2,2,2-trifluoroethylthio; a C6-10 arylthio group such as a phenylthio group, or a nanylthio group; a 5- to 6-membered heteroarylthio group such as a thiazolylthio group, or a pyridylthio group; an alkylsulfinyl group Cl-6 such as a methylsulfinyl group, an ethylsulfinyl group, or a t-butylsulfinyl group; a haloalkylsulfinyl Cl-6 group such as a trifluoromethylsulfinyl group, or a 2,2,2-trifluoroethylsulfinyl group; a C6-10 arylsulfmil group such as a phenylsulfmil group; a 5- to 6-membered heteroarylsulfinyl group such as a 5- to 6-membered thiazolylsulfinyl, or a 5- to 6-membered pyridylsulfinyl; an alkylsulfonyl group Cl-6 such as a methylsulfonyl group, an ethylsulfonyl group, or a t-butylsulfonyl group; a haloalkylsulfonyl Cl-6 group such as a trifluoromethylsulfonyl group, or a 2,2,2-trifluoroethylsulfonyl group; a C6-10 arylsulfonyl group such as a phenylsulfonyl group; a 5- to 6-membered heteroarylsulfonyl group such as a thiazolylsulfonyl group, or a pyridylsulfonyl group; an alkylsulfonyloxy Cl-6 group such as a methylsulfonyloxy group, an ethylsulfonyloxy group, or a t-butylsulfonyloxy group; a haloalkylsulfonyloxy Cl-6 group such as a trifluoromethylsulfonyloxy group, or a 2,2,2-trifluoroethylsulfonyloxy group; a Cl-6 trialkylsilyl group such as a trimethylsilyl group, a triethylsilyl group, or a t-butyldimethylsilyl group; a C6-10 triarylsilyl group such as a triphenylsilyl group; a cyano group; and a nitro group. Additionally, any of the hydrogen atoms in these “substituted groups” may be substituted with other substituted groups that have a different structure. In this case, examples of “substituted groups” include an alkyl group Cl-6, a haloalkyl group Cl-6, an alkoxy group Cl-6, a haloalkoxy group Cl-6, a halogen group, a cyano group, a nitro group, and the like. Furthermore, the aforementioned “3- to 6-membered heterocyclyl group” is a group that has 1 to 4 heteroatoms selected from the group consisting of a nitrogen atom, an oxygen atom, and a sulfur atom as a constituent ring atom. The heterocyclyl group may be a monocyclyl group or a polycyclyl group. As long as at least one ring is a hetero ring in the polyheterocyclyl group, the remaining ring may be a saturated alicyclic ring, an unsaturated alicyclic ring, or an aromatic ring. Examples of the “3- to 6-membered heterocyclyl group” include a saturated 3- to 6-membered heterocyclyl group, a 5- to 6-membered heteroaryl group, a partially unsaturated 5- to 6-membered heterocyclyl group, and the like. Examples of the “3- to 6-membered saturated heterocyclyl group” include an aziridinyl group, an epoxy group, a pyrrolidinyl group, a tetrahydrofuranyl group, a thiazolidinyl group, a piperidinyl group, a piperazinyl group, a morpholinyl group, a dioxolanyl group, a dioxanyl group, and the like. Examples of the “5-membered heteroaryl group” include a pyrrolyl group, a furyl group, a tiendo group, an imidazolyl group, a pyrazolyl group, an oxazolyl group, an isoxazolyl group, a thiazolyl group, an isothiazolyl group, a triazolyl group, an oxadiazolyl group, a thiadiazolyl group, a tetrazolyl group, and the like. Examples of the “6-membered heteroaryl group” include a pyridyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a triazinyl group, and the like. [R',R2] Yo Yo In Formula (I), each of R1 and R2 independently represents a hydrogen atom, a substituted or unsubstituted Cl-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a hydroxyl group, a substituted or unsubstituted Cl-6 alkoxy group, a formyl group, a substituted or unsubstituted Cl-6 alkylcarbonyl group, a substituted or unsubstituted Cl-6 alkoxycarbonyl group, a mercapto group, a substituted or unsubstituted Cl-6 alkylthio group, a substituted or unsubstituted Cl-6 alkylsulfinyl group, a substituted or unsubstituted Cl-6 alkylsulfonyl group, a substituted or unsubstituted aminocarbonyl group, a substituted or unsubstituted C3-8 cycloalkyl group, a substituted or unsubstituted C6-10 aryl group, or a C6-10 aryloxy group. substituted or unsubstituted, a substituted or unsubstituted 3- to 6-membered heterocyclyl group, a substituted or unsubstituted amino group, a halogen group, a cyano group,or a nitrile group, provided that in the case of R2 it is a hydrogen atom, R1 is a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 3- to 6-membered heterocyclyl group. Examples of the “halogen group” of R1 and R2 include a fluorine group, a chlorine group, a bromine group, an iodine group, and the like. The “Cl-6 alkyl group” of R1 and R2 can be linear or branched if it has 3 or more carbon atoms. Examples of alkyl groups include a methyl group, an ethyl group, an n-propyl group, an n-butyl group, an n-pentyl group, an n-hexyl group, an i-propyl group, an i-butyl group, an s-butyl group, a t-butyl group, an i-pentyl group, a neopentyl group, a 2-methylbutyl group, and a 2,2-dimethylpropyl, an i-hexyl group, and the like. Specific examples of the “substituted Cl-6 alkyl group” include a haloalkyl Cl-6 group such as a fluoromethyl group, a chloromethyl group, a bromomethyl group, a difluoromethyl group, a dichloromethyl group, a dibromomethyl group, a trifluoromethyl group, a trichloromethyl group, a tribromomethyl group, a group 1-chloroethyl, a 2,2,2-trifluoroethyl group, a 2,2,2-trichloroethyl group, a pentafluoroethyl group, a 4-fluorobutyl group, a 4-chlorobutyl group, a group 3,3,3-trifluoropropyl, a 2,2,2-trifluoro-l-trifluoromethylethyl group, a perfluorohexyl group, a perchlorohexyl group, or a 2,4,6-trichlorohexyl group; an alkyl Cl-6 alkoxy group such as a methoxymethyl group, an ethoxymethyl group, a methoxyethyl group, an ethoxyethyl group, a methoxy-n-propyl group, an n-propoxymethyl group, an i-propoxyethyl group, an s-butoxymethyl group, or a t-butoxyethyl group; an aryl C6-10 alkyl Cl-6 group such as a benzyl group, or a phenethyl group; a C3-8 alkyl Cl-6 cycloalkyl group such as a cyclopropylmethyl group, a 2-cyclopropylethyl group, a cyclopentylmethyl group, a 2-cyclohexylethyl group, or a 2-cyclooctylethyl group; and the like. Examples of the “C2-6 alkenyl group” of R1 and R2 include a vinyl group, a 1-propendo group, a 2-propenyl group, a 1-butenyl group, a 2-butenyl group, a 3-butenyl group, an l-methyl-2-propenyl group, a 2-methyl-2-propenyl group, a group 1-pentenyl, a group 2-pentenyl, a group 3-pentenyl, a group 4-pentenyl, a group 1-methyl-2-butenyl, a group 2-methyl-2-butenyl, a group 1-hexenyl, a group 2-hexenyl, a 3-hexenyl group, a 4-hexenyl group, a 5-hexenyl group, and the like. Examples of the “substituted C2-6 alkenyl group” include a C2-6 haloalkenyl group such as a 2-chloro-l-propendo group, or a group 2-fluoro-1-butenyl; a C2-6 alkenyl Cl-6 alkoxy group such as a group 2-n-butoxy-vinyl, or a 1-ethoxy-vinyl group; and the like. Examples of the “C2-6 alkynyl group” of R1 and R2 include an ethynyl group, a 1-propynyl group, a 2-propynyl group, a 1-butynyl group, a 2-butynyl group, a 3-butynyl group, a 1-methyl-2-propynyl group, a 2-methyl-3-butynyl group, a group 1-pentynyl, a 2-pentynyl group, a 3-pentynyl group, a 4-pentynyl group, a 1-methyl-2-butynyl, a 2-methyl-3-pentynyl group, a 1-hexynyl group, an l,l-dimethyl-2-butynyl group, and the like. Examples of the “substituted C2-6 alkynyl group” include a C2-6 haloalkynyl group such as a 4,4-dichloro-1-butynyl group, a group 4-fluoro-1-pentynyl, or a 5-bromo-2-pentynyl group. Examples of the “Cl-6 alkoxy group” of R1 and R2 include a methoxy group, an ethoxy group, an n-propoxy group, an n-butoxy group, an n-pentyloxy group, an n-hexyloxy group, an i-propoxy group, an i-butoxy group, an s-butoxy group, a t-butoxy group, an i-hexyloxy group, and the like. Specific examples of the “substituted Cl-6 alkoxy group” include a Cl-6 haloalkoxy group such as a chloromethoxy group, a dichloromethoxy group, a difluoromethoxy group, a trichloromethoxy group, a trifluoromethoxy group, a 1-fluoroethoxy group, a 1,1-difluoroethoxy group, a 2,2,2-trifluoroethoxy group, a pentafluoroethoxy group, or a 2,2,3,4,4,4-hexafluorobutoxy group; a Cl-6 alkoxy group such as a methoxymethoxy group, or a methoxyethoxy group; a C6-10 aryl Cl-6 alkoxy group such as a benzyloxy group or a phenethyloxy group; a C3-8 cycloalkyl Cl-6 alkoxy group such as a cyclopropylmethyloxy group; and the like. Examples of the “alkyl Cl-6 carbonite group” of R1 and R2 include an acetyl group, a propionyl group, and the like. Specific examples of the “substituted alkyl Cl-6 carbonite group” include a haloalkyl Cl-6 carbonite group such as a chloroacetyl group, a trifluoroacetyl group, or a trichloroacetyl group. Examples of the “Cl-6 alkoxycarbonyl group” of R1 and R2 include a methoxycarbonyl group, an ethoxycarbonyl group, an n-propoxycarbonite group, an i-propoxycarbonyl group, a t-butoxycarbonyl group, and the like. Specific examples of the “substituted carbonite alkoxy Cl-6 group” include a carbonite haloalkoxy Cl-6 group such as a fluoromethoxycarbonyl group, a group chloromethoxycarbonyl group, a bromomethoxycarbonyl group, a difluoromethoxycarbonyl group, a dichloromethoxycarbonyl group, a dibromomethoxycarbonyl group, a trifluoromethoxycarbonyl group, a trichloromethoxycarbonyl group, a tribromomethoxycarbonyl group, or a group 2.2.2- trifluoroethoxycarbonyl; a C3-8 alkoxy Cl-6 carbonyl cycloalkyl group such as a cyclopropylmethoxycarbonyl group, a cyclobutylmethoxycarbonyl group, a cyclopentylmethoxycarbonyl group, a cyclohexylmethoxycarbonyl group, or a group 2-cyclopropylethoxycarbonyl; and the like. Examples of the “alkylthio Cl-6 group” of R1 and R2 include a methylthio group, an ethylthio group, an n-propylthio group, an n-butylthio group, an n-pentylthio group, an n-hexylthio group, an i-propylthio group, an i-butylthio group, and the like. Specific examples of the “substituted alkylthio Cl-6 group” include a haloalkylthio Cl-6 group such as a trifluoromethylthio group, or a group 2.2.2- trifluoroethylthio. Examples of the “alkylsulfinyl Cl-6 group” of R1 and R2 include a methylsulfinyl group, an ethylsulfinyl group, a t-butylsulfinyl group, and the like. Specific examples of the “substituted Cl-6 alkylsulfinyl group” include a Cl-6 haloalkylsulfinyl group such as a trifluoromethylsulfinyl group, or a group 2.2.2- trifluoroethylsulfinyl. Examples of the “Cl-6 alkylsulfonyl group” of R1 and R2 include a methylsulfonyl group, an ethylsulfonyl group, a t-butylsulfonyl group, and the like. Specific examples of the “substituted alkylsulfonyl Cl-6 group” include a haloalkylsulfonyl Cl-6 group such as a trifluoromethylsulfonyl group, or a group 2.2.2- trifluoroethylsulfonyl. Examples of preferred substituted groups include the “Cl-6 alkyl group”, “C2-6 alkenyl group”, “C2-6 alkynyl group”, “Cl-6 alkoxy group”, “Cl-6 alkyl carbonyl group”, “Cl-6 alkoxy carbonyl group”, “Cl-6 alkylthio group”, “alkylsulfinyl group” “Cl-6”, and “Cl-6 alkylsulfonyl group” of R1 and R2 preferably include an alkoxy Cl-6 group, a halogen group, a cyano group, a C3-8 cycloalkyl group, a C6-10 aryl group, a 3- to 6-membered heterocyclyl group, and the like. Specific examples of the “substituted aminocarbonyl group” of R1 and R2 include an alkyl Cl-6 aminocarbonyl group such as a methyl aminocarbonyl group, an ethyl aminocarbonyl group, a dimethyl aminocarbonyl group, or a diethyl aminocarbonyl group. Examples of the “C3-8 cycloalkyl group” of R1 and R2 include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, and the like. The C6-10 aryl group of R1 and R2 can be a monocyclic or polycyclic ring. As long as the polycyclic aryl group has at least one aromatic ring, the remaining rings can be a saturated alicyclic ring, an unsaturated alicyclic ring, or an aromatic ring. * Examples of the “C6-10 aryl group” include a phenyl group, a naphthyl group, an azulenyl group, an indenyl group, an indanyl group, a tetralinyl group, and the like. Examples of the “C6-10 aryloxy group” of R1 and R2 include a phenoxy group, a naphthoxy group, and the like. The “3- to 6-membered heterocyclyl group” of R1 and R2 is a group that has 1 to 4 heteroatoms selected from the group consisting of a nitrogen atom, an oxygen atom, and a sulfur atom as a constituent ring atom. The heterocyclyl group can be monocyclic or polycyclic. As long as the polyheterocyclyl group includes at least one heteroring, the remaining ring can be a saturated alicyclic ring, an unsaturated alicyclic ring, or an aromatic ring. Examples of the “3- to 6-membered heterocyclyl group” include a saturated 3- to 6-membered heterocyclyl group, a 5- to 6-membered heteroaryl group, a partially unsaturated 5- to 6-membered heterocyclyl group, and the like. Examples of the “3- to 6-membered saturated heterocyclyl group” include an aziridinyl group, an epoxy group, a pyrrolidinyl group, a tetrahydrofuranyl group, a thiazolidinyl group, a piperidyl group, a piperazinyl group, a morpholinyl group, a dioxolanyl group (specifically, a [1,3]dioxolanyl group), a dioxanyl group (specifically, a [1,3]dioxanyl group, or a [1,4]dioxanyl group), and the like. A 5- to 6-membered saturated heterocyclyl group is preferred. Examples of the 5-membered heteroaryl group include a pyrrolyl group, a furyl group, a thienyl group, an imidazolyl group, a pyrazolyl group, an oxazolyl group, an isoxazolyl group, a thiazolyl group, an isothiazolyl group, a triazolyl group (specifically, a [l,2,3]triazolyl group or a [l,2,4]triazolyl group), an oxadiazolyl group (specifically, a [l,2,4]oxadiazolyl group, or a [l,3,4]oxadiazolyl group), a thiadiazolyl group, a tetrazolyl group, and the like. Examples of the 6-membered heteroaryl group include a pyridyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a triazinyl group, and the like. Examples of the partially unsaturated 5-membered heterocyclyl group include a pyrrolinyl group, an imidazolinyl group (a dihydroimidazolyl group), a pyrazolinyl group, an oxazolinyl group, an isoxazolinyl group, a thiazolinyl group, and the like. Examples of the partially unsaturated 6-membered heterocyclyl group include a thiopyranyl group, a 277-pyridin-l-yl group, a 4H-pyridin-l-yl group, and the like. Examples of substituted groups in the “C3-8 cycloalkyl group”, “C6-10 aryl group”, “C6-10 aryloxy group”, and “3- to 6-membered heterocyclyl group” of R1 and R2 preferably include a halogen group such as an iluoro group, a chlorine group, a bromine group, or an iodine group; a Cl-6 alkyl group such as a methyl group, an ethyl group, an n-propyl group, an n-butyl group, an n-pentyl group, an n-hexyl group, an i-propyl group, an i-butyl group, an s-butyl group, a t-butyl group, an i-pentyl group, a neopentyl group, a 2-methylbutyl group, a 2,2-dimethylpropyl group, or an i-hexyl group; a haloalkyl group Cl-6 such as a chloromethyl group, a chloroethyl group, a trifluoromethyl group, a difluoromethyl group, a 2,2,2-trifluoroethyl group, a perfluoroethyl group, a 1,2-dichloro-n-propyl group, a 1-fluoro-n-butyl group, or a perfluoro-n-pentyl group;a haloalkoxy Cl-6 group such as a trifluoromethoxy group, a 2-chloro-n-propoxy group, or a 2,3-dichlorobutoxy group; an amino group, a monoalkoxy Cl-6 carbonyl group such as a t-butoxycarbonyl amino group; a cyano group; and an oxo group. Examples of substituted groups most preferably include a halogen group such as an iluoro group, a chlorine group, a bromine group, or an iodine group; an Cl-6 alkyl group such as a methyl group, an ethyl group, an n-propyl group, an n-butyl group, an n-pentyl group, an n-hexyl group, an i-propyl group, an i-butyl group, an s-butyl group, a t-butyl group, an i-pentyl group, a neopentyl group, a 2-methylbutyl group, a 2,2-dimethylpropyl group, or an i-hexyl group;a haloalkyl Cl-6 group such as a chloromethyl group, a chloroethyl group, a trifluoromethyl group, a difluoromethyl group, a 2,2,2-trifluoroethyl group, a perfluoroethyl group, a 1,2-dichloro-n-propyl group, a 1-fluoro-n-butyl group, or a perfluoro-n-pentyl group; a haloalkoxy Cl-6 group such as a trifluoromethoxy group, a 2-chloro-n-propoxy group, or a 2,3-dichlorobutoxy group; and an amino group. Examples of substituted groups, in particular, preferably include a fluoro group, a chloro group, a methyl group, and an amino group. Examples of the “substituted amino group” of R1 and R2 include an alkyl Cl-6 amino group such as a methylamino group, an n-butylamino group, a dimethylamino group, or a diethylamino group; a C3-8 cycloalkyl amino group such as a cyclopropylamino group; an alkyl Cl-6 carbonylamino group such as an acetylamino group, a propanoylamino group, a butyrylamino group, or an i-propyl carbonylamino group; a mono(alkoxy Cl-6 carbonyl) amino group such as a methoxycarbonylamino group, an ethoxycarbonylamino group, an n-propoxycarbonylamino group, an i-propoxycarbonylamino group, or a t-butoxycarbonylamino group; a di(alkoxy Cl-6 carbonyl) amino group such as a di(methoxycarbonyl) amino group, a di(ethoxycarbonyl) amino group, a di(i-propoxycarbonyl) amino group, a di(n-propoxycarbonyl) amino group, or a di(t-butoxycarbonyl) amino group; and similar groups. [R3] In Formula (I), R3 represents a substituted or unsubstituted Cl-6 alkylthio group, a substituted or unsubstituted Cl-6 alkylsulfinyl group, a substituted or unsubstituted Cl-6 alkylsulfonyl group, a substituted or unsubstituted Cl-6 alkylsulfonyloxy group, or a group represented by -S(=O)(=N-Ra)-Rb, wherein each of Ra and Rb independently represents a substituted or unsubstituted Cl-6 alkyl group. The examples of “substituted or unsubstituted Cl-6 alkylthio group”, “substituted or unsubstituted Cl-6 alkylsulfinyl group”, and “substituted or unsubstituted Cl-6 alkylsulfonyl group” in R3 include the same examples as those listed in R1 and R2 above. Examples of the “alkylsulfonyloxy Cl-6 group” of R3 include a methylsulfonyloxy group, an ethylsulfonyloxy group, a t-butylsulfonyloxy group, and the like. Examples of preferred substituted groups in the “alkylsulfonyloxy Cl-6 group” of R3 include an alkoxy Cl-6 group, a halogen group, a cyano group, a C3-8 cycloalkyl group, a C6-10 aryl group, a 3- to 6-membered heterocyclyl group, and the like. Specific examples of the “substituted alkylsulfonyloxy group” include a haloalkylsulfonyloxy Cl-6 group such as a trifluoromethylsulfonyloxy group, or a 2,2,2-trifluoroethylsulfonyloxy group. As examples of the “substituted or unsubstituted Cl-6 alkyl group” of Ra and Rb in the group represented by the formula: -S(=O)(=N-Ra)-Rb, the same examples as those listed in the aforementioned R1 and R2 can be mentioned. [R4, R5] In Formula (I), each of R4 and R5 independently represents a hydrogen atom, a halogen group, a cyano group, a substituted or unsubstituted Cl-6 alkyl group, a substituted or unsubstituted C2-6 alkenyl group, a substituted or unsubstituted C2-6 alkynyl group, a hydroxyl group, a substituted or unsubstituted Cl-6 alkoxy group, a formyl group, a substituted or unsubstituted Cl-6 alkylcarbonyl group, a substituted or unsubstituted Cl-6 alkoxycarbonyl group, a substituted or unsubstituted Cl-6 alkylthio group, a substituted or unsubstituted Cl-6 alkylsulfinyl group, a substituted or unsubstituted Cl-6 alkylsulfonyl group, a substituted or unsubstituted Cl-6 alkylsulfonyloxy group, a substituted or unsubstituted amino group, or a group represented by -S(=O)(=N-Ra)-Rb, where each of Ra and Rb independently represents a substituted or unsubstituted Cl-6 alkyl group. As with the examples of the “halogen group” in R4 and R5, the same examples as those stated in R1 and R2 may be mentioned. As for the examples of “substituted or unsubstituted Cl-6 alkyl group”, “substituted or unsubstituted C2-6 alkenyl group”, “substituted or unsubstituted C2-6 alkynyl group”, “substituted or unsubstituted Cl-6 alkoxy group”, “substituted or unsubstituted Cl-6 carbonyl alkyl group”, “substituted or unsubstituted Cl-6 carbonyl alkoxy group”, “substituted or unsubstituted Cl-6 alkylthio group”, “substituted or unsubstituted Cl-6 alkylsulfinyl group”, “substituted or unsubstituted amino group”, and “substituted or unsubstituted Cl-6 alkylsulfonyl group” in R4 and R5, the same examples as those stated in R1 and R2 mentioned above may be mentioned. As with the examples of the “substituted or unsubstituted 6-sulfonyloxy alkyl group” in R4 and R5, the same examples as those stated in the aforementioned R3 may be mentioned. As examples of the “substituted or unsubstituted Cl-6 alkyl group” of Ra and Rb in the group represented by -S(=O)(=N-Ra)-Rb, the same examples as those stated in the aforementioned R1 and R2 can be mentioned. [Ar] In Formula (I), Ar represents a substituted or unsubstituted C6-10 aryl group or a substituted or unsubstituted 5- to 6-membered heteroaryl group. As with the examples of the “C6-10 aryl group” or “5- to 6-membered heteroaryl group” of Ar, the same examples can be mentioned as those stated in An example of substituted “C6-10 aryl group” and “5- to 6-membered heteroaryl group” groups of Ar preferably include a Cl-6 haloalkyl group such as a chloromethyl group, a chloroethyl group, a trifluoromethyl group, a difluoromethyl group, a 2,2,2-trifluoroethyl group, a perfluoroethyl group, a group 1,2-dichloro-n-propyl, a 1-fluoro-n-butyl group, or a perfluoro-n-pentyl group; a haloalkoxy group such as a trifluoromethoxy group, a 2-chloro-n-propoxy group, or a 2,3-dichlorobutoxy group; a haloalkylthio group such as a trifluoromethylthio group, or a 2,2,2-trifluoroethylthio group; and a haloalkylsulfonyl group such as a trifluoromethylsulfonyl group, or a 2,2,2-trifluoroethylsulfonyl group. A more preferred example includes a trifluoromethyl group, a difluoromethyl group, a perfluoroethyl group, a trifluoromethoxy group, a trifluoromethylthio group, or a trifluoromethylsulfonyl group, and in particular, preferably includes a trifluoromethyl group, a perfluoroethyl group, or a trifluoromethoxy group. Ar is preferably a substituted or unsubstituted phenyl group, or a substituted or unsubstituted 5- to 6-membered heteroaryl group, more preferably a substituted phenyl group, a substituted pyrazolyl group, or a substituted pyridyl group, and in particular, preferably a substituted phenyl group. In Formula (I), preferably, R1 is a hydrogen atom, R2 is a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 3- to 6-membered heterocyclyl group (preferably a substituted or unsubstituted 5- to 6-membered heteroaryl group), R3 is a Cl-6 alkylsulfonyl group (preferably an ethylsulfonyl group), R4 is a Cl-6 alkyl group (preferably a methyl group), or a substituted or unsubstituted amino group (preferably an amino group), and R5 is a hydrogen atom. In Formula (I), preferably, R1 is a hydrogen atom, R2 is a substituted or unsubstituted 5- to 6-membered heteroaryl group, R3 is an alkylsulfonyl Cl-6 group (preferably an ethylsulfonyl group), R4 is an alkyl Cl-6 group (preferably a methyl group), and R5 is a hydrogen atom. In Formula (I), preferably, R1 is a hydrogen atom, R2 is a substituted or unsubstituted 5- to 6-membered heteroaryl group, R3 is an alkylsulfonyl Cl-6 group (preferably an ethylsulfonyl group), R4 is a substituted or unsubstituted amino group (preferably an amino group), and R5 is a hydrogen atom. In Formula (I), preferably, R1 is a substituted or unsubstituted C6-10 aryl group (preferably a phenyl group substituted with a halogen group), or a substituted or unsubstituted 3- to 6-membered heterocyclyl group (preferably a substituted or unsubstituted 5- to 6-membered heteroaryl group), R2 is a hydrogen atom, R3 is a Cl-6 alkylsulfonyl group (preferably an ethylsulfonyl group), R4 is a Cl-6 alkyl group (preferably a methyl group), or a substituted or unsubstituted amino group (preferably an amino group), and R5 is a hydrogen atom. In Formula (I), preferably, R1 is a substituted phenyl group (preferably a phenyl group substituted with a halogen group), or a 6-membered heteroaryl group, R2 is a hydrogen atom, R3 is an alkylsulfonyl Cl-6 group (preferably an ethylsulfonyl group), R4 is an alkyl Cl-6 group (preferably a methyl group), and R5 is a hydrogen atom. In Formula (I), preferably, R1 is a substituted phenyl group (preferably a phenyl group substituted with a halogen group), or a 5- to 6-membered heteroaryl group, R2 is a hydrogen atom, R3 is an alkylsulfonyl Cl-6 group (preferably an ethylsulfonyl group), R4 is a substituted or unsubstituted amino group (preferably an amino group), and R5 is a hydrogen atom. A salt of compound (I) is not particularly restricted as long as the salt is an agriculturally and horticulturally acceptable salt. Examples of salts of compound (I) include a salt of an inorganic acid such as hydrochloric acid or sulfuric acid; a salt of an organic acid such as acetic acid or lactic acid; a salt of an alkali metal such as lithium, sodium, or potassium; a salt of an alkaline earth metal such as calcium or magnesium; a salt of a transition metal such as iron or copper; a salt of an organic base such as ammonia, triethylamine, tributylamine, pyridine, or hydrazine; and the like. Compound (I) or a salt thereof is not particularly limited by its method of preparation. For example, compound (I) or its salt can be obtained by the well-known method of preparation described in the working examples and similar ones. Additionally, the salt of compound (I) can be produced from compound (I) by a well-known method. The diarylpyrazole compound of the present invention has a superior effect in controlling harmful organisms such as various agricultural pests that affect plant growth, and mites. Furthermore, the diarylpyrazole compound of the present invention has reduced phytotoxicity to plants and low toxicity to fish or warm-blooded animals, and for this reason, the diarylpyrazole compound of the present invention is a highly safe compound. Therefore, the compound of the present invention is useful as an active ingredient in a pesticide or acaricide. Furthermore, in recent years, many pests such as cabbage moths, leafhoppers, and aphids have developed resistance to various types of conventional agrochemicals, creating a problem where the effectiveness of these products has become insufficient. Therefore, agrochemicals that are effective even against resistant strains of pests are desired. The diarylpyrazole compounds of the present invention exhibit superior effects in controlling not only susceptible strains of pests but also various resistant strains of pests and acaricide-resistant strains of mites. The diarylpyrazole compounds of the present invention have a superior effect in controlling ectoparasites and endoparasites harmful to humans and animals. Additionally, the diarylpyrazole compounds of the present invention have a low level of toxicity to fish and other warm-blooded animals, making them extremely safe. Therefore, the diarylpyrazole compounds of the present invention are useful as an active ingredient in formulations for controlling ectoparasites and endoparasites. Additionally, the diarylpyrazole compounds of the present invention are effective in controlling the target organisms at any stage of development, and exhibit superior control effects, for example, on mites and insects in the egg, nymph, larval, pupal, and adult stages. [Formulation for controlling harmful organisms, insecticide, or acaricide] The formulation for controlling harmful organisms, the insecticide, or the acaricide of the present invention contains at least one compound selected from the diarylpyrazole compounds of the present invention as an active ingredient. The amount of the diarylpyrazole compound contained in the formulation for controlling harmful organisms, the insecticide, or the acaricide of the present invention is not particularly limited, provided that a harmful organism control effect is exhibited. The formulation for controlling harmful organisms, the insecticide, or the acaricide of the present invention is preferably used for crops; green matter; edible roots; tuber crops; flowers; fruit trees; tea, coffee, cocoa or foliage plants; pasture grasses; lawn grasses; plants such as cotton; or the like. Regarding application to plants, the formulation for controlling harmful organisms, the insecticide or acaricide of the present invention can be applied to any part of the plants, such as leaf, stem, flower, bud, fruit, seed, shoot, root, tuber, tuberous root, sprout, cuttings and similar parts. Additionally, the plant varieties for which the formulation for controlling harmful organisms, the insecticide, or the acaricide of the present invention is applicable are not limited in any particular way. Examples of plant varieties include original varieties, improved varieties, cultivated varieties, mutant plants, hybrid plants, genetically modified organisms (GMOs), and similar varieties. The formulations for controlling harmful organisms of the present invention can be used to control various agricultural pests and mites by seed treatment, foliar spraying, soil application, or application to aquatic surfaces and the like. Specific examples of various agricultural pests and mites that can be controlled by the organism control formulations of the present invention are shown below. (1) Lepidoptera Butterflies and Moths (a) Moths belonging to the family Arctiidae, for example, Hyphantria cunea and Lemyra imparilis; (b) Moths belonging to the family Bucculatricidae, for example, Bucculatrix pyrivorella; (c) Carposinidae, for example, Carposina sasakii; (d) Moths belonging to the family Crambidae, for example, Diaphania indica and Diaphania nitidalis of Diaphania spp.; Ostrinia fumaralis, Ostrinia nubilalis and Ostrinia scapulalis from Ostrinia spp.; and others such as Chilo suppressalis, Cnaphalocrocis medinalis, Conogethes punctiferalis, Diatraea grandiosella, Glyphodes pyloalis, Hellula undalis and Parapediasia teterrella; (e) Moths belonging to the family Gelechiidae, for example, Helcystogramma triannulella, Pectinophora gossypiella, Phthorimaea operculella and Sitotroga cerealella; (f) Moths belonging to the Geometridae family, for example, Ascotis selenaria; (g) Moths belonging to the family Gracillariidae, for example, Caloptilia theivora, Phyllocnistis citrella and Phyllonorycter ringoniella; (h) Butterflies belonging to the Hesperiidae family, for example, Pamara guttata; (i) Moths belonging to the family Lasiocampidae, for example, Malacosoma neustria; (j) Moths belonging to the family Lymantriidae, for example, Lymantria dispar and Lymantria monacha of Lymantria spp.; and others such as Euproctis pseudoconspersa and Orgyia thyellina; (k) Moths belonging to the family Lyonetiidae, for example, Lyonetia clerkella and Lyonetia prunifolella malinella of Lyonetia spp.; (1) Moths belonging to the family Noctuidae, for example, Spodoptera depravata, Spodoptera eridania, Spodoptera exigua, Spodoptera frugiperda, Spodoptera littoralis and Spodoptera litura of Spodoptera spp.; Autographa gamma and Autographa nigrisigna of Autographa spp.; Agrotis ypsilon and Agrotis segetum of Agrotis spp.; Helicoverpa armígera, Helicoverpa assulta and Helicoverpa zea of ​​Helicoverpa spp.; Heliothis armígera and Heliothis virescens of Heliothis spp.; and others such as Aedia leucomelas, Ctenoplusia agnata, Eudocima tyrannus, Mamestra brassicae, Mythimna separata, Naranga aenescens, Panolis japónica, Peridroma saucia, Pseudoplusia includens and Trichoplusia ni; (m) Moths belonging to the Nolidae family, for example, Earias insulana; (n) Butterflies belonging to the family Pieridae, for example, Pieris brassicae and Pieris rapae crucivora of Pieris spp.; (o) Moths belonging to the family Plutellidae, for example, Acrolepiopsis sapporensis and Acrolepiopsis suzukiella of Acrolepiopsis spp.; and others such as Plutella xylostella; (p) Moths belonging to the Pyralidae family, for example, Cadra cautella, Elasmopalpus lignosellus, Etiella zinckenella and Galleria mellonella; (q) Moths belonging to the family Sphingidae, for example, Manduca quinquemaculata and Manduca sexta of Manduca spp.; (r) Moths belonging to the family Stathmopodidae, for example, Stathmopoda masinissa; (s) Moths belonging to the family Tineidae, for example, Tinea translucens; (t) Moths belonging to the family Tortricidae, for example, Adoxophyes honmai and Adoxophyes orana of Adoxophyes spp.; Archips breviplicanus and Archips fuscocupreanus of Archips spp.; and others such as Choristoneura fumiferana, Cydia pomonella, Eupoecilia ambiguella, Grapholitha molesta, Homona magnanima, Leguminivora glycinivorella, Lobesia botrana, Matsumuraeses phaseoli, Pandemis heparana and Sparganothis pilleriana; and (u) Moths belonging to the family Yponomeutidae, for example, Argyresthia conjugella. (2) Thysanoptera Insect Pests (a) Phlaeothripidae, for example, Ponticulothrips diospyrosi; and (b) Thripidae, for example, Frankliniella intonsa and Frankliniella occidentalis of Frankliniella spp.; Thrips palmi and Thrips tabaci of Thrips spp.; and others such as Heliothrips haemorrhoidalis and Scirtothrips dorsalis. (3) Pests of Hemipteran Insects (A) Archaeorrhyncha (a) Delphacidae, for example, Laodelphax striatella, Nilaparvata lugens, Perkinsiella saccharicida and Sogatella furcifera. (B) Clypeorrhyncha (a) Cicadellidae, for example, Empoasca fabae, Empoasca nipponica, Empoasca onukii and Empoasca sakaii of Empoasca spp.; and others such as Arboridia apicalis, Balclutha saltuella, Epiacanthus stramineus, Macrosteles striifrons and Nephotettix cinctinceps. (C) Heteropteros (a) Alydidae, for example, Riptortus clavatus; (b) Coreidae, for example, Cletus punctiger and Leptocorisa chinensis; (c) Lygaeidae, for example, Blissus leucopterus, Cavelerius saccharivorus and Togo hemipterus; (d) Miridae, for example, Halticus insularis, Lygus lineolaris, Psuedatomoscelis seriatus, Stenodema sibiricum, Stenotus rubrovittatus and Trigonotylus caelestialium; (e) Pentatomidae, e.g., Nezara antennata and Nezara viridula of Nezara spp.; Eysarcoris aeneus, Eysarcoris lewisi and Eysarcoris ventralis of Eysarcoris spp.; and others such as Dolycoris baccarum, Eurydema rugosum, Glaucias subpunctatus, Halyomorpha halys, Piezodorus hybneri, Plantia crossota and Scotinophora lurida; (f) Pyrrhocoridae, e.g., Dysdercus cingulatus; (g) Rhopalidae, for example, Rhopalus musculatus; (h) Scutelleridae, e.g., Eurygaster integriceps; and (i) Tingidae, for example, Stephanitis nashi. (D) Stemorrhynchus (a) Adelgidae, e.g., Adelges laricis; (b) Aleyrodidae, for example, Bemisia argentifolii and Bemisia tabaci from Bemisia spp.; and others such as Aleurocanthus spiniferus, Dialeurodes citri and Trialeurodes vaporariorum; (c) Aphididae, for example, Aphis craccivora, Aphis fabae, Aphis forbesi, Aphis gossypii, Aphis pomi, Aphis sambuci and Aphis spiraecola of Aphis spp.; Rhopalosiphum maidis and Rhopalosiphum padi of Rhopalosiphum spp.; Dysaphis plantaginea and Dysaphis radicóla of Dysaphis spp.; Macrosiphum avenae and Macrosiphum euphorbiae of Macrosiphum spp.; Myzus cerasi, Myzus persicae and Myzus varians of Myzus spp.; and others such as Acyrthosiphon pisum, Aulacorthum solani, Brachycaudus helichrysi, Brevicoryne brassicae, Chaetosiphon fragaefolii, Hyalopterus pruni, Hyperomyzus lactucae, Lipaphis erysimi, Megoura viciae, Metopolophium dirhodum, Nasonovia ribis-nigri, Phorodon humuli, Schizaphis graminum, Sitobion avenae and Toxoptera aurantii; (d) Coccidae, por ejemplo, Ceroplastes ceríferas y Ceroplastes rabens de Ceroplastes spp.; (e) Diaspididae, for example, Pseudaulacaspis pentagona and Pseudaulacaspis pranicola of Pseudaulacaspis spp.; Unaspis euonymi and Unaspis yanonensis of Unaspis spp.; and others such as Aonidiella aurantii, Comstockaspis perniciosa, Fiorinia theae and Pseudaonidia paeoniae; (f) Margarodidae, for example, Drosicha corpulenta and Icerya purchasi; (g) Phylloxeridae, for example, Viteus vitifolii; (h) Pseudococcidae, for example, Planococcus citri and Planococcus kuraunhiae of Planococcus spp.; and others such as Phenacoccus solani and Pseudococcus comstocki; and (i) Psyllidae, for example, Psylla mali and Psylla pyrisuga of Psylla spp.; and others such as Diaphorina citri. (4) Polyphagous Insect Pests (a) Anobiidae, for example, Lasioderma serricome; (b) Attelabidae, for example, Byctiscus betulae and Rhynchites heros; (c) Bostrichidae, for example, Lyctus brunneus; (d) Brentidae, for example, Cylas formicarius; (e) Buprestidae, por ejemplo, Agrilus sinuatus; (f) Cerambycidae, for example, Anoplophora malasiaca, Monochamus altematus, Psacothea hilaris and Xylotrechus pyrrhoderus; (g) Chrysomelidae, for example, Bruchus pisorum and Bruchus rufímanus of Bruchus spp.; Diabrotica barberi, Diabrotica undecimpunctata and Diabrotica virgifera of Diabrotica spp.; Phyllotreta nemorum and Phyllotreta striolata of Phyllotreta spp.; and others such as Aulacophora femoralis, Callosobruchus chinensis, Cassida nebulosa, Chaetocnema concinna, Leptinotarsa ​​decemlineata, Oulema oryzae and Psylliodes angusticollis; (h) Coccinellidae, for example, Epilachna varivestis and Epilachna vigintioctopunctata of Epilachna spp.; (i) Curculionidae, for example, Anthonomus grandis and Anthonomus pomorum of Anthonomus spp.; Sitophilus granarius and Sitophilus zeamais of Sitophilus spp.; and others such as Echinocnemus squameus, Euscepes postfasciatus, Hylobius abietis, Hypera postica, Lissohoptrus oryzophilus, Otiorhynchus sulcatus, Sitona lineatus and Sphenophorus venatus; (j) Elateridae, for example, Melanotus fortnumi and Melanotus tamsuyensis of Melanotus spp.; (k) Nitidulidae, for example, Epuraea domina; (l) Scarabaeidae, por ejemplo, Anómala cuprea and Anómala rufocuprea de Anómala spp.; and others such as Cetonia aurata, Gametis jucunda, Heptophylla picea, Melolontha and Popillia japónica; (m) Scolytidae, for example, Ips typographus; (n) Staphylinidae, for example, Paederus fuscipes; (o) Tenebrionidae, por ejemplo, Tenebrio molitor and Tribolium castaneum; y (p) Trogossitidae, por ejemplo, Tenebroides mauritanicus.

[0089] (5) Dipteran Insect Pests (A) Brachycerans (a) Agromyzidae, for example, Liriomyza bryoniae, Liriomyza chinensis, Liriomyza sativae and Liriomyza trifolii of Liriomyza spp.; and others such as Chromatomyia horticola and Agromyza oryzae; (b) Anthomyiidae, for example, Delia platura and Delia radicum of Delia spp.; and others such as Pegomya cunicularia; (c) Drosophilidae, for example, Drosophila melanogaster and Drosophila suzukii of Drosophila spp.; (d) Ephydridae, for example, Hydrellia griseola; (e) Psilidae, for example, Psila rosae; and (f) Tephritidae, for example, Bactrocera cucurbitae and Bactrocera dorsalis of Bactrocera spp.; Rhagoletis cerasi and Rhagoletis pomonella from Rhagoletis spp.; and others such as Ceratitis capitata and Dacus oleae. (B) Nematocera (a) Cecidomyiidae, for example, Asphondylia yushimai, Contarinia sorghicola, Mayetiola destructor and Sitodiplosis mosellana. (6) Orthopteran Insect Pests (a) Acrididae, for example, Schistocerca americana and Schistocerca gregaria of Schistocerca spp.; and others such as Chortoicetes terminifera, Dociostaurus maroccanus, Locusta migratoria, Locustana pardalina, Nomadacris septemfasciata and Oxya yezoensis; (b) Gryllidae, for example, Acheta domestica and Teleogryllus emma; (c) Gryllotalpidae, for example, Gryllotalpa orientalis; and (d) Tettigoniidae, for example, Tachycines asynamorus. (7) Mites (A) Acaridida of Astigmata (a) Mites of the family Acaridae, for example, Rhizoglyphus echinopus and Rhizoglyphus robini of Rhizoglyphus spp.; Tyrophagus neiswanderi, Tyrophagus pemiciosus, Tyrophagus putrescentiae and Tyrophagus similis from Tyrophagus spp.; and others such as Acaras siró, Aleuroglyphus ovatus and Mycetoglyphus fungivoras; (B) Actinedida of Prostigmata (a) Mites of the family Tetranychidae, for example, Bryobia praetiosa and Bryobia rabrioculus of Bryobia spp.; Eotetranychus asiaticus, Eotetranychus boreus, Eotetranychus celtis, Eotetranychus geniculatus, Eotetranychus kankitus, Eotetranychus prani, Eotetranychus shii, Eotetranychus smithi, Eotetranychus suginamensis and Eotetranychus uncatus of Eotetranychus spp.; Oligonychus hondoensis, Oligonychus ilicis, Oligonychus karamatus, Oligonychus mangiferas, Oligonychus orthius, Oligonychus perseae, Oligonychus pustulosus, Oligonychus shinkajii and Oligonychus ununguis of Oligonychus spp.; Panonychus citri, Panonychus morí and Panonychus ulmi of Panonychus spp.; Tetranychus cinnabarinus, Tetranychus kanzawai, Tetranychus ludeni, Tetranychus quercivorus, Tetranychus phaselus, Tetranychus urticae and Tetranychus viennensis from Tetranychus spp.; Aponychus corpuzae and Aponychus firmianae from Aponychus spp.; Sasanychus akitanus and Sasanychus pusillus from Sasanychus spp.; Shizotetranychus celarius, Shizotetranychus longus, Shizotetranychus miscanthi, Shizotetranychus recki y Shizotetranychus schizopus de Shizotetranychus spp.; y otros tales como Tetranychina harti, Tuckerella pavoniformis y Yezonychus sapporensis;. (b) Carcas of the family Tenuipalpidae, for example, Brevipalpus lewisi, Brevipalpus obovatus, Brevipalpus phoenicis, Brevipalpus rassulus and Brevipalpus califomicus of Brevipalpus spp.; Tenuipalpus pacificus y Tenuipalpus zhizhilashviliae de Tenuipalpus spp.; and other tales like Dolichotetranychus floridanus; (c) Mites of the family Eriophyidae, for example, Steel diospyri, Steel ficus, Steel japonica, Steel kuko, Steel paradianthi, Steel tiyingi, Steel tulipae and Steel zoysiea of ​​Steel spp.; Eriophyes chibaensis and Eriophyes emarginatae of Eriophyes spp.; Aculops lycopersici and Aculops pelekassi from Aculops spp.; Aculus fockeui and Aculus schlechtendali of Aculus spp.; and others such as Acaphylla theavagrans, Calacarus carinatus, Colomerus vitis, Calepitrimerus vitis, Epitrimerus pyri, Paraphytoptus kikus, Paracalacarus podocarpi and Phyllocotruta citri; (d) Mites of the family Tarsonemidae, for example, Tarsonemus bilobatus and Tarsonemus waitei of Tarsonemus spp.; and others such as Phytonemus pallidus and Polyphagotarsonemus latus; and (e) Mites of the family Penthaleidae, e.g., Penthaleus erythrocephalus and Penthaleus major from Penthaleus spp. The formulation for controlling harmful organisms of the present invention can be mixed or used in combination with other active constituents such as fungicides, insecticides / acaricides, nematicides and soil pesticides; and / or plant regulators, herbicides, synergists, fertilizers, soil conditioners and animal feed. Combinations of the compound of the present invention with other active constituents can be expected to provide synergistic effects in terms of insecticidal / acaricidal / nematicidal activity. The synergistic effect can be confirmed according to a conventional method by means of an equation defined by Colby (Colby, S.R.; Calculating Synergistic and Antagonistic Responses of Herbicide Combinations; Weeds, 15, pp. 20-22, 1967). Examples of insecticides / acaricides, nematicides, soil pesticides, vermicides and the like which can be mixed or used together with the formulation to control harmful organisms according to the present invention are described below. (1) Acetylcholinesterase inhibitor: (a) Agentes a base de carbamato: alanicarb, aldicarb, bendiocarb, benfuracarb, butocarboxim, butoxicarboxim, carbaril, carbofuran, carbosulfan, etiofencarb, fenobucarb, formetanato, furatiocarb, isoprocarb, metiocarb, metomil, oxamil, pirimicarb, propoxur, tiodicarb, tiofanox, triazamato, trimetacarb, XMC, xililcarb, fenotiocarb, MIPC, MPMC, MTMC, aldoxicarb, alixicarb, aminocarb, bufencarb, cloetocarb, metam-sodio, y promecarb;and (b) Organic phosphorus-based agents: acephate, azamethiphos, azinphos-ethyl, azinphos-methyl, cadusaphos, chlorethoxyphos, chlorfenvinphos, chlormephos, chlorpyrifos, chlorpyrifos-methyl, coumaphos, cyanophos, demeton-S-methyl, diazinon, dichlorvos / DDVP, dicrotophos, dimethoate, dimethylvinphos, disulfoton, EPN, ethion, ethoprophos, famfur, fenamiphos, fenitrothion, fenthion, fostiazate, heptenophos, imiciaphos, isofenphos, isocarbophos, isoxation, malathion, mecarbam, methamidophos, methidathion, mevinphos, monocrotophos, naled, omethoate, oxidemeton-methyl, parathion, parathion-methyl, fenthoate, phorate, phosalone, phosmet, fosfamidon, phoxim, pirimifos-methyl, profenofos, propetamphos, prothiofos, pyraclofos, pyridafenthion, quinalfos, sulfotep, tebupirimphos, temephos, terbufos, tetrachlorvinphos, thiometon, triazophos, trichlorfon, vamidothion;bromophos-ethyl, BRP, carbofenothion, cyanofenphos, CYAP, demeton-S-methyl sulfone, dialyphos, diclofenthion, dioxabenzophos, etrimphos, fensulfothion, flupyrazophos, fonofos, formotion, fosmethylan, isazophos, jodfenphos, metacryphos, pirimiphos-ethyl, phosphocarb, propaphos, protoate, and sulprofos.; (2) GABA-regulated chloride ion channel antagonists: acetoprol, chlordane, endosulfan, etiprol, fipronil, pirafiuprol, pyriprol, campeflor, heptachlor, and dienochlor. (3) Sodium channel modulators: acrinathrin, d-cis-trans-allethrin, d-trans-allethrin, bifenthrin, bioallethrin, S-cyclopentyl-bioallethrin isomer, bioresmethrin, ci-oprotrin, cyfluthrin, β-cyfluthrin, cyhalothrin, λ-cyhalothrin, γ-cyhalothrin, cypermethrin, α-cypermethrin, β-cypermethrin, θ-cypermethrin, ξ-cypermethrin, cyfenothrin [(IR)-trans isomer], δ-methrin, empentrin [(EZ)-(IR) isomer], esfenvalerate, etofenprox, fenpropatrin, fenvalerate, flucithrinate, flumethrin, tau-fluvalinate, halfenprox, imiprothrin, kadethrin, permethrin, phenothrin [isomer (IR)-trans], praletrin, pyrethrum, resmethrin, silafluofen, tefluthrin, tetramethrin [(IR) isomer], tralomethrin, transfluthrin; allethrin, pyrethrins, pyrethrin I, pyrethrin II, profluthrin, dimefluthrin, bioethanemetrin, biopermethrin, transpermethrin, fenfluthrin, fenpythrin, flubrocitrinate, flufenprox, metofluthrin, protripenbute, pyresmethrin, and teraletrin. (4) Nicotinic acetylcholine receptor agonists: acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, nithiazine, thiacloprid, thiamethoxam, sulfoxaflor, nicotine, and ilupiradifurone. (5) Nicotinic allosteric modulators of the acetylcholine receptor: spinetoram, and spinosad. (6) Chloride channel activators: abamectin, emamectin-benzoate, lepimectin, milbemectin, ivermectin, selamectin, doramectin, eprinomectin, moxidectin, milbemycin; milbemycin oxime, and nemadectin. (7) Juvenile hormone-like substances: hydroprene, quinoprene, methoprene, phenoxycarb, pyriproxyfen, diophenolan, epophenonane, and triprene. (8) Other non-specific inhibitors: methyl bromide, chloropicrin, sulfuryl fluoride, borax, and tartar emetic. (9) Substances with selective antifeedant activity towards homopterans: flonicamid, pymetrocin, and pyrifluquinazon. (10) Mite growth inhibitors: clofentecin, diflovidazine, hexythiazox, and etoxazole. (11) Disrupting agents of the internal membrane of the midgut of insects derived from microorganisms: Bacillus thuringiensis subsp. Israelensis, Bacillus sphaericus, Bacillus thuringiensis subsp. Aizawai, Bacillus thuringiensis subsp. Kurstaki, Bacillus thuringiensis subsp. Tenebrionis, Bt crop protein: CrylAb, CrylAc, CrylFa, CrylA. 105, Cry2Ab, Vip3A, mCry3A, Cry3Ab, Cry3Bb, and Cry34Abl / Cry35Abl. (12) Enzyme inhibitors of mitochondrial ATP biosynthesis: diafenthiuron, azocyclotine, cyhexatine, phenbutatine oxide, propargite, and tetradifon. (13) Oxidative phosphorylation uncouplers: chlorfenapyr, sulfluramide, DNOC; binapacril, dinobuton, and dinocap. (14) Nicotinic acetylcholine receptor channel blockers: bensultap, cartap hydrochloride; nereistoxin; thiosultap-sodium, and thiocyclam. (15) Chitin synthesis inhibitors: bistrifluron, chlorfluazuron, diflubenzuron, flucicloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron, triflumuron, buprofezin, and fluazuron. (16) Molting obstructors of diptera: cyromazine. (17) Molting hormone receptor agonists: chromafenozide, halofenozide, methoxyfenozide, and tebufenozide. (18) Octopamine receptor agonists: amitraz, demiditraz, and chlordimeform. (19) Inhibitors of complex III of the mitochondrial electron transfer chain: acequinocil, fluacripyrim, and hydramethylnon. (20) Inhibitors of complex I of the mitochondrial electron transfer chain: phenazaquine, fenpyroximate, pirimidifen, pyridaben, tebufenpyrad, tolfenpyrad, and rotenone. (21) Voltage-dependent sodium channel blockers: indoxacarb, and metaflumizone. (22) Acetyl CoA carboxylase inhibitors: spirodiclofen, spiromesifen, and spirotetramate. (23) Inhibitors of complex IV of the mitochondrial electron transfer chain: aluminum phosphide, calcium phosphide, phosphine, zinc phosphide, and cyanide. (24) Inhibitors of mitochondrial electron transfer chain complex II: cyenopyrafen, cyflumethofen, and piflubumide. (25) Ryanodine receptor modulators: chlorantraniliprole, cyantraniliprole, flubendiamide, cyclaniprole, and tetraniliprol. (26) Mixed-function oxidase inhibitor compounds: piperonyl butoxide. (27) Iatrophilin receptor agonists: depsipeptide, cyclodepsipeptide, 24-membered cyclodepsipeptide, and emodepside. (28) Other (unknown action mechanism): azadirachtin, benzoximate, bifenazate, bromopropylate, quinomethionate, cryolita, dicofol, pyridalil, benclotiaz, azufre, amidoflumet, 1, 3-dichloropropeno, DCIP, fenisobromolate, benzomato, metaldehído, chlorobencylate, clothiazoben, dicylanil, fenoxacrim, fentrifanil, flubencimine, flufenacin, gossyplure, japonilure, metoxadiazona, aceite, oleate potassium, tetrasul; triarateno, afidopyropen, phlometoquine, flufiprol, fluensulfona, meperflutrina, tetramethylfluthrin, tralopyril, dimefluthrin, methylneodecanamide; fluralaner, afoxolaner, and fluxametamida, 5-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihidroisoxazol- 3-yl]-2-(lH-l,2,4-triazol-l-yl)benzonitrilo (CAS: 943137-49-3), broflanilida, otras meta-diamidas, steinemema carpocapsae, steinemema glaseri, pasteuria penetrans, paecilomyces tenuipes, paecilomyces fumosoroseus, beauveria bassiana, beauveria brongniartii, metarhizium anisopliae, y verticillium lecanii. (29) Parasiticide: (a) Benzimidazole-based agents: fenbendazole, albendazole, triclabendazole, oxibendazole, mebendazole, oxfendazole, parbendazole, flubendazole, febantel, netobimine, thiophanate; thiabendazole, and cambendazole; (b) Salicylanilide-based agents: closantel, oxyclozanide, rafoxanide, and niclosamide; (c) Substituted phenol-based agents: nitroxinil, and nitroscanate; (d) Pyrimidine-based agents: pyrantel, and morantel; (e) Imidazothiazole-based agents: levamisole, and tetramisole; (f) Tetrahydropyrimidine-based agents: praziquantel, and epsiprantel; and (g) Other antiparasitic agents: cyclodien, riania, clorsulon, metronidazole, demiditraz, piperazine, diethylcarbamazine, dichlorophen, monepantel, tribendimidine, amidantel, thiacetarsamide, melarsomine, and arsenamide. Specific examples of fungicides that can be mixed or used in conjunction with the formulation to control harmful organisms according to the present invention are described below. (1) Inhibitors of nucleic acid biosynthesis: (a) RNA polymerase I inhibitors: benalaxyl, benalaxyl-M, furalaxyl, metalaxyl, metalaxyl-M, oxadixyl; clozilacon, and ofurace; (b) Adenosine deaminase inhibitors: bupirimate, dimetirimol, and etirimol; (c) Inhibitors of DNA / RNA synthesis: hymexazole, and octylinone; and (d) Inhibitors of DNA topoisomerase II: oxolinic acid. (2) Karyokinesis inhibitor and cell division inhibitors: (a) β-tubulin polymerization inhibitors: benomyl, carbendazim, chlorphenazole, fuberidazole, thiabendazole, thiophanate, thiophanate-methyl, dietofencarb, zoxamide, and etaboxam; (b) Cell division inhibitors: pencicuron; and (c) Spectrin-like protein delocalization inhibitors: fluopicolide. (3) Respiratory inhibitors: (a) NADH oxidoreductase Complex I inhibitors: diflumetorim and tolfenpyrad; (b) Succinic acid dehydrogenase complex II inhibitors: benodanil, flutolanil, mepronil, isofetamide, fluopyram; fenfuram, furmeciclox, carboxin, oxycarboxin, tiphluzamide, benzovindiflupyr, bixafen, fluxapyroxad, furamethir, isopirazam, penflufen, penthiopyrad, sedaxane, boscalid, and pyraziflumide; (c) Ubiquinol oxidase Qo complex III inhibitors: azoxystrobin, coumoxystrobin, coumethoxystrobin, enoxastrobin, fluphenoxystrobin, picoxystrobin, pyroxystrobin, pyraclostrobin, pyramethostrobin, triclopyricarb, kresoxim-methyl, trifloxystrobin, dimoxystrobin, phenaminostrobin, methominostrobin, orisastrobin, famoxadone; fluoxastrobin, fenamidone, piribencarb, and mandestrobin; (d) Qi Ubiquinol Reductase Complex III Inhibitors: cyazofamide and amisulbrom; (e) Uncoupling agents of oxidative phosphorylation: binapacril, meptyldinocap, dinocap, fluazinam, and ferimzone; (f) Inhibitors of oxidative phosphorylation (ATP synthase inhibitors): fentine acetate, fentine chloride, and fentine hydroxide; (g) ATP production inhibitors: siltiofam; and (h) Complex III: cytochrome bel (ubiquinone reductase) inhibitors Qx (unknown): ametoctradine. (4) Inhibitors of amino acid and protein synthesis: (a) Inhibitors of methionine biosynthesis: andoprim, cyprodinil, mepanipirim, and pyrimethanil; and (b) Inhibitors of protein synthesis: blasticidin S; kasugamycin, kasugamycin hydrochloride, streptomycin, and oxytetracycline. (5) Signal transduction inhibitors: (a) Signal transduction inhibitors: quinoxyfen and proquinazide; and (b) MAP / histidine kinase inhibitors in signal transduction involved in osmotic pressure: fenpiclonil, fludioxonil, clozolinate, iprodione, procymidone, and vinclozolin. (6) Inhibitors of lipid and cell membrane synthesis: (a) Inhibitors of phospholipid biosynthesis and methyltransferase: edifenfos, iprobenfos, pyrazofos, and isoprothiolane; (b) Lipid peroxidation agents: biphenyl, chloroneb, dichloran, quintocene, technacene, tolclofos-methyl, and etridiazole; (c) Agents that act on cell membranes: iodocarb, propamocarb, propamocarb-hydrochloride, propamocarb-fosetylate, and prothiocarb; (d) Microorganisms that disrupt cell membranes of pathogens: Bacillus subtilis, Bacillus subtilis strain QST713, Bacillus subtilis strain FZB24, Bacillus subtilis strain MBI600, Bacillus subtilis strain D747, and Bacillus amyloliquefaciens; and (e) Agents that disrupt cell membranes: Melaleuca altemifolia (tea tree) extract. (7) Inhibitors of cell membrane sterol biosynthesis: (a) Inhibitors of demethylation at the C14 position in sterol biosynthesis: triforine, pyrifenox, pyrisoxazole, fenarimol, flurPrimol, nuarimol, imazalil, imazalyl sulfate, oxpoconazole, pefurazoate, prochloraz, triflumizole, viniconazole, azaconazole, bitertanol, bromuconazole, cyproconazole, diclobutrazol, difenoconazole, diniconazole, diniconazol-M, epoxiconazole, etaconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, furconazole, furconazole-cis, hexaconazole, imibenconazole, ipconazole, metconazole, myclobutanil, penconazole, propiconazole, fluquinconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, prothioconazole, voriconazole, and mefentrifluconazole; (b) Δ14 reductase and Δ8—*A7-isomerase inhibitors in sterol biosynthesis: aldimorph, dodemorph, dodemorph acetate, fenpropimorf, tridemorph, fenpropidine, piperaline, and spiroxamine; (c) 3-keto reductase inhibitors in demethylation at the C4 position in sterol biosynthesis systems: fenhexamide and fenpyrazamine; and (d) squalene epoxidase inhibitors in sterol biosynthesis systems: pyributicarb, naftifen, and terbinafine. (8) Inhibitors of cell wall synthesis: (a) Trehalase inhibitors: validamycin; (b) Chitin synthase inhibitors: polyoxins and polyoxorim; and (c) Cellulose synthase inhibitors: dimethomorph, flumorph, pirimorph; bentiavalicarb isopropyl, iprovalicarb, tolprocarb, valifenalate, and mandipropamide. (9) Inhibitors of melanin biosynthesis: (a) Reductase inhibitors in melanin biosynthesis: phthalide, piroquilon, and tricyclazole; and (b) Anhydrase inhibitors in melanin biosynthesis: carpropamide, diclocimet, and phenoxanil. (10) Resistance-inducing agents in host plants: (a) Agent acting on the salicylic acid biosynthetic pathway: acibenzolar-S-methyl; and (b) Others: probenazole; thiadinyl; isothiadinyl; laminarin; and Reynoutria sachalinensis extract. (11) Agents for which the mode of activity is not clear: cymoxanil, fosetyl-aluminum, phosphoric acid (phosphate), teclophthalam, triazoxide, flusulfamide, diclomezine, metasulfocarb, cyflufenamide, metrafenone, pyriophenone, dodine, dodine free base, and flutianil. (12) Agents having multiple activities: copper (copper salts), Bordeaux mixture, copper hydroxide, copper naphthalate, copper oxide, copper oxychloride, copper sulfate, sulfur, sulfur products, calcium polysulfide, ferbam, mancozeb, maneb, mancobre, metiram, polycarbamate, propineb, thiram, zineb, ziram, captan, captafol, folpet, chlorothalonil, diclofluanide, tolylfluanide, guazatine, iminoctadine triacetate, iminoctadine trialbesilate, anilazine, dithianon, quinomethionate, and fluoroimide. (13) Other agents: DBEDC, folpet fluoride, guazatine acetate, copper (II) bis(8-quinolinolate), propamidine, chloropicrin, cyprohuram, agrobacterium, betoxazin, diphenylamine, methyl isothiocyanate (MITC), mildi omi ciña, capsaicin, curfraneb, ciprosulfamide, dazomet, debacarb, dichlorophen, flumetover, fosetyl calcium, fosetyl sodium, irumamycin, natamycin, nitrothal isopropyl, oxamocarb, pyrrolnitrine, tebufloquine, tolnifanide, zarilamide, algofase, amicartiazole, oxathiapiproline, metiram zinc, benthiazole, triclamide, uniconazole, oxyfenthiin, picarbutrazox, fenpicoxamide, diclobenthiazox, quinofumeline, thiuram, ambam, agrobacterium radiobacter, coniothyrium minitans, pseudomonas fluorescens, pseudomonas rhodesiae, talaromyces flavus, trichoderma atroviride, erwinia carotovora subsp. carotovora, bacillus simplex, variovorax paradoxus, and lactobacillus plantarum. Specific examples of plant growth regulators that can be mixed or used in combination with the formulation of the present invention to control harmful organisms are set out below. Abscisic acid, kinetin, benzylaminopurine, 1,3-diphenylurea, forchlorfenuron, thidiazuron, chlorfenuron, dihydrozeatin, gibberelin A, gibberelin A4, gibberelin A7, gibberelin A3, 1-methylcyclopropane, N-acetylaminoethoxyvinylglycine (alternative name: aviglycine), aminooxyacetate, silver nitrate, cobalt chloride, IAA, 4-CPA, cloprop 2,4-D, MCPB, indole-3-butyrate, dichlorprop, phenothiol, 1-naphthylacetamide, eticlozate, cloxifonac, maleic acid hydrazide, 2,3,5-triiodobenzoic acid, salicylic acid, methyl salicylate, (-)-jasmonic acid, methyl jasmonate, (+)-strigol, (+)-deoxystrigol, (+)-orobanchol, (+)-sorgolactone, 4-oxo-4-(2-phenylethyl)aminobutyric acid, ethephon, chlormequat, mepiquat chloride, benzyladenine, 5-aminolevulinic acid, and daminozide. Formulation to control ectoparasites The formulation for controlling ectoparasites according to the present invention contains at least one compound selected from the diarylpyrazole compounds of the present invention as an active ingredient. The diarylpyrazole compounds of the present invention exhibit superior effects for the control of ectoparasites that are harmful to animals and humans. Examples of ectoparasites include mites, lice, fleas, mosquitoes, stable flies, flesh flies, and the like. Examples of host animals for which the ectoparasite control formulation of the present invention is effective include warm-blooded animals such as pets like dogs or cats; birds; farm animals such as cattle, horses, pigs, or sheep; domestic fowl; and the like. Additionally, honeybees, beetles, and unicorn beetles may be mentioned. Ectoparasites live on or in their host animals, especially warm-blooded animals. More specifically, ectoparasites are parasites that live on the back, armpits, lower abdomen, inner thighs, and similar parts of their host animals, obtaining nutrients such as blood and dander. The ectoparasite control formulation of the present invention can be applied by a known veterinary method (topical, oral, parenteral, or subcutaneous administration). Examples of such methods include a method for orally administering tablets, capsules, and drinks mixed with the ectoparasite control formulation to animals; a method for administration to animals by means of a dip, suppository, or injection (intramuscular, subcutaneous, intravenous, intra-abdominal, or the like); a method for the topical administration of an oil- or water-based liquid preparation by spraying, pouring, spot-on application, or similar methods; a method for topical administration by applying a collar, ear tag, or similar device made by molding a mixture obtained by kneading the ectoparasite control formulation with a resin to animals; and the like. Specific examples of ectoparasites that can be avoided by means of the formulation for controlling ectoparasites according to the present invention are described below. (1) Mites Mites belonging to the family Dermanyssidae, mites belonging to the family Macronyssidae, mites belonging to the family Laelapidae, mites belonging to the family Varroidae, mites belonging to the family Argasidae, mites belonging to the family Ixodidae, mites belonging to the family Psoroptidae, mites belonging to the family Sarcoptidae, mites belonging to the family Knemidokoptidae, mites belonging to the family Demodixidae, mites belonging to the family Trombiculidae, and parasitic mites of insects such as Coleopterophagus berlesei. (2) of the order Phthiraptera Lice belonging to the family Haematopinidae, lice belonging to the family Linognathidae, biting lice belonging to the family Menoponidae, biting lice belonging to the family Philopteridae, and biting lice belonging to the family Trichodectidae. (3) order of Siphonaptera Fleas belonging to the Pulicidae family, for example, Ctenocephalides canis and Ctenocephalides felis of Ctenocephalides spp.; Fleas belonging to the family Tungidae, fleas belonging to the family Ceratophyllidae, and fleas belonging to the family Leptopsyllidae. (4) of the order of hemiptera. (5) Harmful organism of the order Diptera Mosquitoes belonging to the Culicidae family, black flies belonging to the Simuliidae family, sucking bugs belonging to the Ceratopogonidae family, flies belonging to the Tabanidae family, flies belonging to the Muscidae family, tsetse flies belonging to the Glossinidae family, flesh flies belonging to the Sarcophagidae family, flies belonging to the Hippoboscidae family, flies belonging to the Calliphoridae family, and flies belonging to the Oestridae family; Formulation for the Control of Endoparasites or Parasiticide An endoparasite control or parasiticide formulation of the present invention contains at least one compound selected from the diaryl-pyrazole compounds of the present invention as an active ingredient. The parasites to which the endoparasite control formulation or parasiticide of the present invention is directed live within the bodies of host animals, and particularly within the bodies of warm-blooded animals and fish (basically, endoparasites).Examples of host animals for which the endoparasite control or parasiticide formulation of the present invention is effective include warm-blooded animals such as humans, domestic mammals (e.g., cows, horses, pigs, sheep, and goats and similar animals), experimental animals (e.g., mice, rats, and hamsters and similar animals), pets (e.g., hamsters, guinea pigs, dogs, cats, horses, squirrels, rabbits, and ferrets and similar animals), wild mammals and zoo mammals (e.g., monkeys, foxes, deer, and buffalo and similar animals), domestic poultry (e.g., turkeys, ducks, chickens, quail, and geese, and similar birds), and pet birds (e.g., pigeons, parrots, myna birds, Java finches, parakeets, Bengal finches, and canaries and similar birds); and fish such as salmon, trout, koi carp and similar fish.By controlling or exterminating parasites, parasitic diseases can be prevented or treated. Examples of parasites that can be controlled or exterminated include those mentioned below. (1) Nematodes of the order Dioctophymatids (Dioctophymatida) (a) Kidney worms of the family Dioctophymatidae, for example, Dioctophyma renale of Dioctophyma spp.; and (b) Kidney worms of the family Soboliphymatidae, for example, Soboliphyme abei and Soboliphyme baturini of Soboliphyme spp. (2) Nematodes of the order Whipworms (Trichocephalida) (a) Trichina worms of the family Trichinellidae, for example, Trichinella spiralis of Trichinella spp.; and (b) Whipworms of the family Trichuridae, for example, Capillaria annulata, Capillaria contorta, Capillaria hepatica, Capillaria perforans, Capillaria plica and Capillaria suis of Capillaria spp.; and Trichuris vulpis, Trichuris discolor, Trichuris ovis, Trichuris skrjabini and Trichuris suis from Trichuris spp. (3) Nematodes of the order Rhabditida Pinworms of the family Strongyloididae, for example, Strongyloides papillosus, Strongyloides planiceps, Strongyloides ransomi, Strongyloides suis, Strongyloides stercoralis, Strongyloides tumefaciens and Strongyloides ratti of Strongyloides spp. (4) Nematodes of the order Strongylida Ancylostomes of the family Ancylostomatidae, for example, Brazilian Ancylostoma, Ancylostoma caninum, Ancylostoma duodenale and Ancylostoma tubaeform of Ancylostoma spp.; Uncinaria stenocephala from Uncinaria stenocephala; and Bunostomum phlebotomum and Bunostomum trigonocephalum of Bunostomum spp. (5) Nematodes of the order Strongylid (Strongylida) (a) Nematodes of the family Angiostrongylidae, for example, Aelurostrongylus abstrusus from Aelurostrongylus spp.; and Angiostrongylus vasorum and Angiostrongylus cantonesis of Angiostrongylus spp.; (b) Nematodes of the family Orenosomatidae, for example, Crenosoma aerophila and Crenosoma vulpis from Crenosoma spp.; (c) Nematodes of the family Filaroididae, for example, Filaroides hirthi and Filaroides osleri of Filaroides spp.; (d) Lungworms of the family Metastrongylidae, for example, Metastrongylus apri, Metastrongylus asymmetricus, Metastrongylus Pundotectus and Metastrongylus salmi of Metastrongylus spp.; and (e) Gapeworms of the family Syngamidae, for example, Cyathostoma bronchialis of Cyathostoma spp.; and Syngamus skrjabinomorpha and Syngamus trachea from Syngamus spp. (6) Nematodes of the order Strongylida (a) Nematodes of the family Molineidae, for example, Nematodirus filicollis and Nematodirus spathiger of Nematodirus spp.; (b) Nematodes of the family Dictyocaulidae, for example, Dictyocaulus filarial and Dictyocaulus viviparus of Dictyocaulus spp.; (c) Nematodes of the family Haemonchidae, for example, Haemonchus contortus of Haemonchus spp.; and Mecistocirrus digitatus of Mecistocirrus spp.; (d) Nematodes of the family Haemonchidae, for example, Ostertagia ostertagi of Ostertagia spp.; (e) Nematodes of the family Heligmonellidae, for example, Nippostrongylus braziliensis of Nippostrongylus spp.; and (f) Nematodes of the family Trichostrongylidae, for example, Trichostrongylus axei, Trichostrongylus colubriformis and Trichostrongylus tenuis of Trichostrongylus spp.; Hyostrongylus rubidus of Hyostrongylus spp.; and Obeliscoides cuniculi of Obeliscoides spp. (7) Nematodes of the order Strongylida (a) Nematodes of the family Chabertiidae, for example, Chabertia ovina of Chabertia spp.; and Oesophagostomum brevicaudatum, Oesophagostomum columbianum, Oesophagostomum dentatum, Oesophagostomum georgianum, Oesophagostomum maplestonei, Oesophagostomum quadrispinulatum, Oesophagostomum radiatum, Oesophagostomum venulosum and Oesophagostomum watanabei of Oesophagostomum spp.; (b) Nematodes of the family Stephanuridae, for example, Stephanurus dentatus of Stephanurus spp.; and (c) Nematodes of the family Strongylidae, for example, Strongylus asini, Strongylus edentatus, Strongylus equinus and Strongylus vulgaris of Strongylus spp. (8) Nematodes of the order Oxyurids (Oxyurida) Nematodes of the family Oxyuridae, for example, Enterobius anthropopitheci and Enterobius vermicularis from Enterobius spp.; Oxyuris equi from Oxyuris spp.; and Passalurus ambiguus from Passalurus spp. (9) Nematodes of the order Ascaridids (Ascaridida) (a) Nematodes of the family Ascaridiidae, for example, Ascaridia galli of Ascaridia spp.; (b) Nematodes of the family Heterakidae, for example, Heterakis beramporia, Heterakis brevispiculum, Heterakis gallinarum, Heterakis pusilla and Heterakis putaustralis of Heterakis spp.; (c) Nematodes of the family Anisakidae, for example, Anisakis simplex of Anisakis spp.; (d) Nematodes of the family Ascarididae, for example, Ascaris lumbricoides and Ascaris suum of Ascaris spp.; and Parascaris equorum from Parascaris spp.; and (e) Nematodes of the family Toxocaridae, for example, Toxocara canis, Toxocara leonina, Toxocarasuum, Toxocara vitulorum and Toxocara cati of Toxocara spp. (10) Nematodes of the order Spiruridae (a) Nematodes of the family Onchocercidae, for example, Brugia malayi, Brugia pahangi and Brugia patei of Brugia spp.; Dipetalonema reconditum of Dipetalonema spp.; Dirofilaria immitis of Dirofilaria spp.; Filaria oculi of Filaria spp.; and Onchocerca cervicalis, Onchocerca gibsoni and Onchocerca gutturosa of Onchocerca spp. (b) Nematodes of the family Setariidae, for example, Setaria digitata, Setaria equina, Setaria labiatopapillosa and Setaria marshalli of Setaria spp.; and Wuchereria bañerofti from Wuchereria spp.; and (c) Nematodes of the family Filariidae, for example, Parafilaria multipapillosa of Parafilaria spp.; and Stephanofilaria assamensis, Stephanofilaria dedoesi, Stephanofilaria kaeli, Stephanofilaria okinawaensis and Stephanofilaria stilesi from Stephanofilaria spp. (11) Nematodes of the order Spiruridae (a) Nematodes of the family Gnathostomatidae, for example, Gnathostoma doloresi and Gnathostoma spinigerum of Gnathostoma spp.; (b) Nematodes of the family Habronematidae, for example, Habronema majus, Habronema microstoma and Habronema muscae of Habronema spp.; and Draschia megastoma from Draschia spp.; (c) Nematodes of the family Physalopteridae, for example, Physaloptera canis, Physaloptera cesticillata, Physaloptera erdocyona, Physaloptera felidis, Physaloptera gemina, Physaloptera papilloradiata, Physaloptera praeputialis, Physaloptera pseudopraerutialis, Physaloptera rara, Physaloptera sibirica and Physaloptera vulpineus of Physaloptera spp.; (d) Nematodes of the family Gongylonematidae, for example, Gongylonema pulchrum of Gongylonema spp.; (e) Nematodes of the Spirocercidae family, for example, Ascarops strongylina of Ascarops spp.; y (f) Nematodes of the Thelaziidae family, for example, Thelazia callipaeda, Thelazia gulosa, Thelazia lacrymalis, Thelazia rhodesi and Thelazia skrjabini of Thelazia spp. Formulation para el Control de Otros Organismos perjudiciales Additionally, the formulations for controlling harmful organisms of the present invention exhibit a superior effect in controlling other pests that have a sting or venom that can harm humans and animals, pests that carry various pathogens / pathogenic bacteria, and pests that impart a sense of discomfort to humans (such as toxic pests, insect pests in sanitary environments, nuisance insect pests). Specific examples are mentioned below. (1) Hymenoptera insect pests Flying insects of the Argidae family, wasps of the Cynipidae family, flying insects of the Diprionidae family, ants of the Formicidae family, wasps of the Mutillidae family, and wasps of the Vespidae family. (2) Other insect pests Blattodea, termites, Araneae, centipedes, millipedes, crustaceans and Cimex lectularius. The diarylpyrazole compounds of the present invention have superior insecticidal effects with respect to whiteflies, thrips, grasshoppers, Blattodea, Phyllotreta striolata, and similar insects, among the aforementioned harmful organisms. EXAMPLES Examples of Formulation Some examples of formulations for controlling harmful organisms, insecticides, acaricides, formulations for controlling ectoparasites, or formulations for controlling or expelling endoparasites of the present invention are described below. The additives and addition ratios are not limited to those in the examples and may be modified in a wide range. The term “part” in the formulation examples means “part by weight.” Examples of formulations for agricultural and horticultural use and for rice paddies are described below. Formulation 1: Wettable powder parts of a diarylpyrazole compound of the present invention, 53 parts of diatomaceous earth, 4 parts of a higher alcohol sulfuric ester, and 3 parts of an alkylnaphthalenesulfonic acid salt were uniformly mixed and finely pulverized to obtain a wettable powder including 40% of an active ingredient. Formulation 2: Emulsion parts of the diarylpyrazole compound of the present invention, 33 parts of xylene, 30 parts of dimethylformamide and 7 parts of a polyoxyethylene alkyl aryl ether were mixed and dissolved to obtain an emulsion including 30% of an active ingredient. Formulation 3: Granules Parts of the diarylpyrazole compound of the present invention, 40 parts of talc, 38 parts of clay, 10 parts of bentonite and 7 parts of sodium alkyl sulfate were uniformly mixed and finely pulverized, followed by granulation to obtain a granulated form having a diameter of 0.5 to 1.0 mm to obtain granules containing 5% of an active ingredient. Formulation 4: Granules Five parts of the diarylpyrazole compound of the present invention, 73 parts of clay, 20 parts of bentonite, 1 part of sodium dioctyl sulfosuccinate, and 1 part of potassium phosphate were thoroughly pulverized and mixed. Water was added, and the mixture was thoroughly kneaded, followed by granulation and drying to obtain granules containing 5% of an active ingredient. Formulation 5: Suspension Ten parts of the diarylpyrazole compound according to the present invention, four parts of polyoxyethylene alkyl allyl ether, two parts of sodium polycarboxylate, ten parts of glycerol, 0.2 parts of xanthan gum, and 73.8 parts of water were mixed and wet-sprayed to obtain a particle size of 3 microns or smaller. This resulted in a suspension containing 10% of an active ingredient. Examples of formulations for controlling ectoparasites, or formulations for controlling or expelling endoparasites, are described below. Formulation 6: Granulated powder Five parts of the diarylpyrazole compound of the present invention were dissolved in an organic solvent to obtain a solution. This solution was then sprayed onto 94 parts of kaolin and 1 part of white charcoal, followed by evaporation of the solvent under reduced pressure. This granulated powder can be mixed with animal feed. Formulation 7: Formulation for impregnation 0.1 to 1 parts of the diarylpyrazole compound of the present invention and 99 to 99.9 parts of peanut oil were uniformly mixed, and then sterilized by filtration using a sterilization filter. Formulation 8: Formulation for pouring 5 parts of the diarylpyrazole compound of the present invention, 10 parts of a myristic ester, and 85 parts of isopropanol were uniformly mixed to obtain a pourable formulation. Formulation 9: Formulation for topical “spot-on” application 10 to 15 parts of the diarylpyrazole compound of the present invention, 10 parts of a palmitic ester, and 75 to 80 parts of isopropanol were uniformly mixed to obtain a formulation for topical application. Formulation 10: Spray formulation 1 part of the diarylpyrazole compound of the present invention, 10 parts of propylene glycol and 89 parts of isopropanol were uniformly mixed to obtain a spray formulation. The following are examples of compounds to explain the present invention more specifically. It should be understood that the present invention is not limited to the following examples of compounds. Example 1 Synthesis of 3-(ethylsulfonyl)-2-(5-methyl-4-(4-(trifluoromethoxy)phenyl)-12 / -pyrazol-l-yl)-6-(l / 7-l,2,4-triazol-l-yl)pyridine (Compound No. 1-1) Etapa 1 Síntesis de 5-amino-1-(3-fluoropyridin-2-yl)-1H-pyrazol-4-carboxilato de etilo N2H4·H?O N' % *· HzN.. BOH H' J reflux EtO' CN .COOEt E(O The reflux 2,3-Difluoropyridine (2.4 g) was dissolved in ethanol (42 mL), and hydrazine hydrate (10.5 g) was added. The mixture was stirred for 3 hours under heating and reflux. The solution from the aforementioned reaction was concentrated, and water was added to the resulting residue. The mixture was then subjected to ethyl acetate extraction. The organic layer obtained was dried over anhydrous magnesium sulfate and filtered. The filtrate was concentrated under reduced pressure. The resulting residue (2.3 g) was dissolved in ethanol (31 mL), and ethyl (ethoxymethylene)cyanoacetate (3.1 g) was added. The mixture was stirred overnight under heating and reflux. The solution from the aforementioned reaction was concentrated, and water was added to the resulting residue. The mixture was then subjected to ethyl acetate extraction. The organic layer obtained was dried on anhydrous magnesium sulfate, and filtered.The filtered material was concentrated under reduced pressure, and the resulting residue was purified by silica gel column chromatography. This yielded 4.1 g of the target product (91% yield). A 1H-NMR image of the target product is shown below. 1 H-NMR (400 MHz, CDC13): δ 8.26 (d, 1H), 7.84 (s, 1H), 7.66 (m, 1H), 7.28 (m, 1H), 6.92 (br s, 2H), 4.31 (q, 2H), 1.37 (t, 3H). Step 2 Synthesis of l-(3-fluoropyridin-2-yl)-177-pyrazol-5-amine Ethyl 5-amino-l-(3-fluoropyridin-2-yl)-177-pyrazol-4-carboxylate (2.1 g) was dissolved in concentrated hydrochloric acid (10 mL), and the mixture was stirred for 4 hours under heating and reflux. The reaction solution was added to water and neutralized by adding potassium carbonate. The mixture was then subjected to dichloromethane extraction. The resulting organic layer was washed with a saturated aqueous sodium chloride solution, dried over anhydrous magnesium sulfate, and filtered. The filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography. The target product was obtained in an amount of 1.2 g (77% yield). 1H-NMR of the obtained target product is shown below. 1 H-NMR (400 MHz, CDC13): δ 8.24 (d, 1H), 7.64 (m, 1H), 7.52 (s, 1H), 7.24 (m, 1H), 5.60 (d, 1H), 5.23 (br s, 2H). Step 3 Synthesis of 4-bromo-l-(3-fluoropyridin-2-yl)-l / 7-pyrazole-5-amine NH2 Br2 AcOH ta NH2 1.2 g of l-(3-fluoropyridin-2-yl)-l / 7-pyrazol-5-amine was dissolved in 6 mL of acetic acid, 1.0 g of bromine was added, and the reaction mixture was stirred for one hour at room temperature. The reaction solution was added to water and neutralized by adding potassium carbonate. The reaction solution was then subjected to extraction with ethyl acetate. The resulting organic layer was washed with a saturated aqueous sodium chloride solution, dried over anhydrous magnesium sulfate, and then filtered. The filtrate was concentrated under reduced pressure and purified by silica gel column chromatography. The target product was thus obtained in an amount of 1.6 g (93% yield). 1 H-NMR of the target product obtained is shown below. 1 H-NMR (400 MHz, CDCb): δ 8.25 (d, 1H), 7.65 (m, 1H), 7.52 (s, 1H), 7.27 (m, 1H), 5.38 (brs, 2H). Stage 4 Synthesis of 1 -(3-fluoropyridin-2-yl)-4-(4-(trifluoromethoxy)phenyl)1 H-pyrazole-5-amine pOC F3-PhB(OH)£ Pd(OAc)£ X-Phos K3PO1 Toluene Reflux water 4-bromo-l-(3-fluoropyridin-2-yl)-177-pyrazol-5-amine (0.51 g) was dissolved in toluene (5 ml), and water (1.7 ml), 4-(trifluoromethoxy)phenylboronic acid (0.61 g), palladium(II) acetate (0.022 g), X-Phos (0.095 g), and potassium phosphate (0.84 g). The reaction mixture was stirred for 3 hours under an argon atmosphere with heating and reflux. The reaction solution was added to water and extracted with ethyl acetate. The resulting organic layer was washed with a saturated aqueous sodium chloride solution, dried over anhydrous magnesium sulfate, and then filtered. The filtrate was concentrated under reduced pressure and purified by silica gel column chromatography. The target product was obtained in an amount of 0.47 g (70% yield). 1H-NMR of the obtained target product is shown below. 1 H-NMR (400 MHz, CDCb): δ 8.28 (d, 1H), 7.71 (s, 1H), 7.68 (m, 1H), 7.48 (m, 2H), 7.29 (m, 2H), 5.51 (br s, 2H). Stage 5 Synthesis of 3-fluoro-2-(5-iodo-4-(4-(trifluoromethoxy)phenyl)-l / 7pyrazol-1-yl)pyridine l2 tBuONO l-(3-fluoropyridin-2-yl)-4-(4-(trifluoromethoxy)phenyl) was dissolved W-Pyrazol-5-amine (0.47 g) was dissolved in chloroform (10 mL) and then cooled to 0°C. Iodine (0.68 g) and tertiary butyl nitrite (0.30 mL) were added, and the mixture was stirred for several hours at room temperature. The solution from the aforementioned reaction was added to water and extracted with ethyl acetate. The resulting organic layer was washed with a saturated aqueous sodium chloride solution, dried over magnesium sulfate, and then filtered. The filtrate was concentrated under reduced pressure and purified by silica gel column chromatography. The target product was thus obtained in an amount of 0.56 g (89% yield). 1 H-NMR of the target product obtained is shown below. 1 H-NMR (400 MHz, CDC13): δ 8.50 (d, 1H), 7.94 (s, 1H), 7.72 (m, 1H), 7.63 (m, 2H), 7.54 (m, 1H), 7.31 (m, 2H). Stage 6 Synthesis of 3-fhioro-2-(5-methyl-4-(4-(trifluorornetoxy)phenyl)-177pyrazol-1 -yl)pyridine MeBOh PdíPPh3)4 Cs2CO3 Dioxane Water 100°C It dissolved 3-fluoro-2-(5-iodo-4-(4-(trifluoromethoxy)phenyl)-l / 7-pyrazol-l-yl)pyridine (0.56 g) was dissolved in a solvent mixture of dioxane (13 ml) and water (1.5 ml), and trimethylboroxine (0.47 g), tetrakis(triphenylphosphatase) palladium (0) (0.14 g), and cesium carbonate (1.2 g) were added. The reaction mixture was stirred under a nitrogen atmosphere for i The mixture was heated overnight at 100°C. The solution from the aforementioned reaction was added to water and extracted with ethyl acetate. The resulting organic layer was washed with a saturated aqueous sodium chloride solution, dried over magnesium sulfate, and then filtered. The filtrate was concentrated under reduced pressure and purified by silica gel column chromatography. The target product was obtained in a quantity of 0.33 g (98% yield). 1H-NMR of the obtained target product is shown below. 1 H-NMR (400 MHz, CDCh): δ 8.44 (d, 1H), 7.86 (s, 1H), 7.69 (m, 1H), 7.46 (m, 2H), 7.44 (m, 1H), 7.29 (m, 2H), 2.45 (s, 3H). Stage 7 Summary of 3-(ethylthio)-2-(5-methyl-4-(4-(trifluoromethoxy)phenyl)-177-pyrazol-l-yl)pyridine NaSEt DMF / THF 50°C 3-Fluoro-2-(5-methyl-4-(4-(trifluoromethoxy)phenyl)l / Z-pyrazol-l-yl)pyridine (0.33 g) was dissolved in a solvent mixture of tetrahydrofuran (6 mL) and MAM-1-methylformamide (3 mL), and the mixture was stirred at room temperature. Sodium ethyl mercaptanate (80%, 0.15 g) was added, and the mixture was stirred for 4 hours at 50°C. Water was added to the reaction solution, and the mixture was then subjected to ethyl acetate extraction. The resulting organic layer was washed with a saturated aqueous sodium chloride solution, dried over magnesium sulfate, and then filtered. The filtrate was concentrated under reduced pressure and purified by silica gel column chromatography. Thus, the target product was obtained in an amount of 0.34 g (91% yield). 1 µH NMR of the target product obtained is shown below. 1 H-RMN (400 MHz, CDC13): δ 8.37 (dd, 1H), 7.83 (s, 1H), 7.78 (dd, 1H), 7.48 (m, 2H), 7.37 (dd, 1H), 7.27 (m, 2H), 2.91 (q, 2H), 2.38 (s, 3H), 1,32 (t, 3H). Etapa 8 Síntesis de 1-óxido de 3-(etilsulfonil)-2-(5-metil-4-(4-(trifluorometoxi)fenil)\H-pirazol-l-il)piridina i) ínCPBA chci3 La. ..............................>· ii) 30% H2O2 c. H2SOí Agua La. 3-(Ethylthio)-2-(5-methyl-4-(4-(trifluoromethoxy)phenyl)-177-pyrazol-l-yl)pyridine (0.34 g) was dissolved in chloroform (10 mL) and stirred at 0°C. Metachloroperbenzoic acid (70%, 0.64 g) was added, and the mixture was stirred overnight at room temperature. The reaction solution was added to a saturated aqueous sodium bicarbonate solution and a saturated aqueous sodium thiosulfate solution and extracted with dichloromethane. The resulting organic layer was washed with a saturated aqueous sodium chloride solution, dried over magnesium sulfate, and then filtered. The filtered material was concentrated under reduced pressure, and the resulting residue was dissolved in a mixture of water (0.33 ml) and concentrated sulfuric acid (1.0 ml). Hydrogen peroxide (30%, 0.11 ml) was added, and the mixture was stirred overnight at room temperature.The reaction solution was added to water, neutralized by adding potassium carbonate, and then extracted with ethyl acetate. The resulting organic layer was washed with a saturated aqueous sodium chloride solution, dried over anhydrous magnesium sulfate, and then filtered. The filtrate was concentrated under reduced pressure and purified by silica gel column chromatography. The target product was obtained in a quantity of 0.21 g (55% yield). 1H-NMR of the obtained target product is shown below. 1 H-NMR (400 MHz, CDCh): δ 8.54 (dd, 1H), 7.97 (dd, 1H), 7.93 (s, 1H), 7.60 (dd, 1H), 7.49 (m, 2H), 7.27 (m, 2H), 3.60 - 3.31 (m, 2H), 2.29 (s, 3H), 1.32 (t, 3H). Stage 9 Synthesis of 6-chloro-3-(ethylsulfonyl)-2-(5-methyl-4-(4-(trifluoromethoxy)phenyl)-177-pyrazol-1-yl)pyridine POCIj reflux Phosphorus oxychloride (1.0 ml) was added to 1-oxide of 3-(ethylsulfonyl)-2-(5-methyl-4-(4-(trifluoromethoxy)phenyl)-177-pyrazol-l-yl)pyridine (0.21 g) was added, and the mixture was stirred for 4 hours under heating and reflux. The reaction solution was added to water and neutralized by adding sodium bicarbonate. The reaction solution was then subjected to extraction with ethyl acetate. The resulting organic layer was washed with a saturated aqueous sodium chloride solution, dried over anhydrous magnesium sulfate, and then filtered. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography. The target product was obtained in an amount of 0.13 g (60% yield). 1H-NMR of the obtained target product is shown below. 1 H-NMR (400 MHz, CDCh): δ 8.48 (d, 1H), 7.78 (s, 1H), 7.62 (d, 1H), 7.46 (m, 2H), 7.28 (m, 2H), 3.76 (q, 2H), 2.45 (s, 3H), 1.36 (t, 3H). Stage 10 Synthesis of 3-(ethylsulfonyl)-2-(5-methyl-4-(4-(trifluoromethoxy)phenyl)177-pyrazol-l-yl)-6-(177-l,2,4-triazol-l-yl)pyridine (Compound No. 1-1) 1,2,4-Triazole NaH DMF ta Sodium hydride (approximately 60%, 0.015 g) was added to Λζ / V-dimethylformamide (4 ml) was suspended therein, and 1,2,4-triazole (0.024) was added g) inside at 0°C. The mixture was stirred for 30 minutes. Added 6-chloro-3-(ethylsulfonyl)-2-(5-methyl-4-(4-(trifluoromethoxy)phenyl)-l / 7-pyrazol-l-yl)pyridine (0.13 g) was added and stirred for 2 hours at room temperature. The reaction solution was added to water and extracted with ethyl acetate. The resulting organic layer was washed with a saturated aqueous sodium chloride solution, dried over anhydrous magnesium sulfate, and then filtered. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography. The target product was obtained in an amount of 0.10 g (72% yield). 1H-NMR of the obtained target product is shown below. 1 H-NMR (400 MHz, CDC13): δ 9.15 (s, 1H), 8.73 (d, 1H), 8.20 (d, 1H), 8.19 (s, 1H), 7.83 (s, 1H), 7.50 (m, 2H), 7.30 (m, 2H), 3.76 (q, 2H), 2.48 (s, 3H), 1.39 (t, 3H). Table 1 shows the compounds according to the present invention prepared by the same methods as those described in the Examples mentioned above. Table 1 shows the substituents of the compounds represented by Formula (1-1). The physical properties of the compounds are described in the “Physical Property” columns. The physical property data includes the melting point (mp). In the Tables, Me represents a methyl group, Et represents an ethyl group, and Boc represents a tert-butoxycarbonyl group. (I -1) Table 1 Compound no. R1 R2 R3 R4 R5 Ar Physical Property 1-1 H 1H-1,2,4-triazole-1-yl SO2Et Me H 4-OCF3-phenyl pf:145-147(°C) 1-2 H pyrimidine-2-yl SO2Et Me H 4-OCF3-phenyl pf:81-80-182°C(H) 3-CH3-1H-1,2,4-tr¡azol-1-ilo SO2Et Me H 4-OCF3-phenyl pf:202-204(°C) 1-4 H 3-NH2-1H-1,2,4-triazol-1-ilo SO2Et Me H 4-OCF3-phenyl pf:16-64(°C) 5-NH2-1H-1,2,4-tr¡azol-1-ilo SO2Et Me H 4-OCF3-phenyl pf:236-238(°C) 1-6 H 3-CI-1 / - / -1,2,4-triazol-1-ilo SO2Et Me H 4-OCF3-phenyl pf:236-238(°C) H 3-CF3-1 H-pyrazol-1-ilo SO2Et Me H 4-OCF3-phenyl pf:160-164(°C) 1-8 H pyrrolidin-1-ilo SO2Et Me H 4-OCF3-phenyl pf:171-173(°C) 1-9 H 4-Phenyl pf:171-173(°C) 1-9 H 4-Mel H 4-OCF3-amorphous phenyl 1-10 H SMe SO2Et Me H 4-OCF3-amorphous phenyl 1-11 H SOMe SO2Et Me H 4-OCF3-amorphous phenyl 1-12 H SO2Me SO2Et Me H 4-OCF3-phenyl amorphous 1-14 Cl Cl SO2Et Me H 4-OCF3-phenyl pf:135-137(°C) 1-15 Cl 1 / 7-1,2,4-triazol-1-ilo SO2Et Me H 4-OCF3-phenyl pf: 158-161 (°C). Table 1 (continued) Compound D1 no. K R2 R3 R4 R5 Ar Physical property 1-16 H 3-NH2-1 / - / -pyrazol-1 -yl SO2Et Me H 4-OCF3-phenyl pf:178-181(°C) 1-17 H cyclopropylamine SO2Et Me H 4-OCF3-phenyl amorphous 1-18 H 4-NH2-1H-pyrazol-1-¡lo SO2Et Me H 4-OCF3-phenyl pf:87-90(°C) 1-19 H 1H-1, 2,4-triaz H 6-CF2CF3- pyridine-3-ilo pf:108-110(°C) 1-20 H 3-CN- 1H-1,2,4-triazol-1-ilo SO2Et Me H 4-OCF3-phenyl pf:222-226(°C) 1-21 H 3-NHBoc- 1 / - / -1,2,4-triazol-1-ilo SO2Et Me H 6-CF3-pyr¡din-3-ilo pf:138-141(°C) 1-22 H 3-NHBoc- 1H-1,2,4-triazol-1-ilo SO2Et Me H I-SO2-IH-Il pf:147-149(°C) 1-23 H 3-NH2- 1 / 7-1,2,4-triazol-1-ilo SO2Et Me H 6-CF3-pyridin-3-ilo pf:170-173(°C) 1-24 H 3-NH2- 1 / 7-1-Metrizol-1-Hazol-Et I-SO2CF3-IH- pyrazole-4-ilo pf:220-221(°C) 1-25 H Cl SO2Et Me H 4-OCF3-phenyl pf:145-147(°C) 1-26 H OH SO2Et Me H 4-OCF3-phenyl pf:70-80(°C-87 H) 1 / 7-¡m¡dazol-1-¡lo SO2Et Me H 4-OCF3-phenyl pf:175-177(°C) 1-28 H 4-F-phenyl SO2Et Me H 4-OCF3-phenyl pf:132-134(°C) 1-29 H SO2Et MeH-3-4-phenyl pf:109-111(°C) 1-30 H OEt SO2Et Me H 4-OCF3-phenyl pf:105-107(°C) 1-31 H OCH2CF3 SO2Et Me H 4-OCF3-phenyl pf:112-114(°C) 1-32 H NHCOEt SO2Et Me H 4-OCF3-phenyl pf:75-77(°C).

[0168] Table 1 (continued) Compound no. R1 R2 R3 R4 R5 The Physical Property 1-33 3,5-F2-phenyl H SO2Et Me H I-SO2CF3- 1 H-pyrazole-4-ilo pf:160-162(°C) 1-34 H 1 / 7-1,2,4- triazole-1-ilo H pf:230(°C) up 1-35 3,5-F2-phenyl H SO2Et nh2 H 4-OCF3-phenyl pf:208-210(°C) 1-36 H OEt SO2Et nh2 H 4-OCF3-phenyl pf:140-140-14-F2-F2-315-phenyl H SO2Et nh2 H 6-CF3pyridin-3-ilo pf:231-234(°C) 1-38 3,5-F2-phenyl H SO2Et nh2 H 4-SCF3-phenyl pf:220-221(°C) 1-39 3,5-F2-phenyl H 23-Et H-CF-E pyridine-3-ilo pf:222-224(°C) 1-40 4-OCF3-phenyl H SO2Et nh2 H 4-OCF3-phenyl pf:184-186(°C) 1-41 pyrimidine-2-ilo H SO2Et nh2 H 4-OCF3-phenyl pf:212-214(°C) 1-42 pyrimidine-2-ilo H SO2Et nh2 H 4-CF3-phenyl pf:250-252(°C) 1-43 pyrimidine-2-ilo HSO 4-CF2CF3-phenyl pf:250-252(°C) 1-44 3,5-F2-phenyl H SO2Et nh2 H 4-CF3-phenyl pf:233-236(°C) 1-45 pyrimidine-2-ilo H SO2Et nh2 H 6-pyridine-CF3-ilo pf:270-273(°C) 1-46 pyrimidine-2-ilo H SO2Et nh2 H 4-SCF3-phenyl pf:201-205(°C) 1-47 pyrimidine-2-ilo H SO2Et Me H 4-OCF3-phenyl pf:177-180(48°C) 1-49°C pyrimidine-2-ilo HH 1H-1,2,4- triazole-1 -lio SO2Et SO2Et Me nh2 HH I-CHF2- 1 Hp yrazol-4-i lo 4-OCF3-phenyl pf:161-164(°C) pf:186-188(°C) 1H-1-2-E nh2 H 5-CF3pyridin-3-ilo pf:256-258(°C) Table 1 (continued) No. - R1 R2 R3 R4 R5 The Physical Property 1-51 1H-1,2,4-tr¡azol-1-yl H SO2Et nh2 H 4-OCF3-phenyl pf:159-161(°C) 1-52 pyrimidine-2-yl H SO2Et Me H 1-H 4-H-Il :163-165(°C) 1-53 1H-1,2,4-triazole-1-ilo H SO2Et nh2 H 5-CF3-pyrid¡n-3-ilo pf:223-224(°C) 1-54 5-CF3-pyridin-2-ilo H SO2Ethiol nh-OCF-O pf:219-221 (°C) 1-55 pyrimidine-2-ilo H SO2Et Me H 1-CH2CF3-1H-pyrazole-4-ilo pf:164-166(°C) 1-56 5-CF3-pyridin-2-¡lo H SO2Et nh2 H 6-CF-ilo pf:244-246(°C) In Table 2 are shown the 'H-NMR (400 MHz, CDCh) data of some compounds among the compounds described in Table 1. Table 2 Compound no. 1-9 1-10 1-11 1-12 1-13 1-17 NMR data (ppm) 8.71 (1H, d), 8.32-8.26 (2H, m), 7.82 (1H, s), 7.61 (1H, d), 7.51-7.46 (2H, m), 7.33-7.27 (2H, m), 6.58-6.51 (2H, m), 2.3, q s), 1.39 (3H, t). 8,23 (1H, d), 7,78 (1H, s), 7,52-7,46 (2H, m), 7,41 (1H, d), 7,31-7,24 (2H, m), 3,68 (2H, q), 2,60 (3H, s), 2,43 (3H, s), 1,34 (3H,t). 8,80 (1H, d), 8,35 (1H, d), 7,81 (1H, s), 7,50-7,43 (2H, m), 7,33-7,27 (2H, m), 3,79 (2H, q), 2,95 (3H, s), 2,41 (3H,s), 1,39 (3H, t). 8,84 (1H, d), 8,32 (1H, d), 7,82 (1H, s), 7,52-7,44 (2H, m), 7,33-7,28 (2H, m), 3,88 (2H, q), 3,30 (3H, s), 2,50 (3H, s), 1,41 (3H,t). 9,43 (2H, s), 9,37 (1H, s), 8,70 (1H, d), 8,07 (1H, d), 7,83 (1H, s), 7,55-7,48 (2H, m), 7,35-7,27 (2H, m), 3,81 (2H, q), 2,51 (3H, s), 1,40 (3H, t). 8,23 (1H, d), 7,75 (1H, s), 7,49-7,42 (2H, m), 7,30-7,20 (2H, m), 6,91 (1H, d), 5,64 (1H, brs), 3,46 (2H, q), 2,69-2,59 (1H, br m), 2,36 (3H, s), 1,28 (3H, t), 0,97-0,88 (2H, m), 0,71-0,60 (2H, m). As described above, the diarylpyrazole compounds according to the present invention can be readily produced using known chemical reactions as described in the Examples mentioned above. A person skilled in the art will readily understand from the descriptions in the specification of this application that they can be produced by the methods mentioned above and similar methods, and that other compounds not specifically shown in the specification of this application can be used, i.e., compounds having various substituted groups, provided that these do not exceed the scope and extent of the present invention. Biological assays The following Test Examples demonstrate that the diarylpyrazole compounds of the present invention (hereinafter referred to as “compounds of the present invention”) are useful as active ingredients in formulations for controlling harmful organisms and formulations for controlling ectoparasites. The term “part” is a function of weight. Emulsion preparation for testing 5 parts of the compound of the present invention, 93.6 parts of dimethylformamide and 1.4 parts of polyoxyethylene alkyl aryl ether were mixed and dissolved to prepare Emulsion (I) which included 5% of an active ingredient. A mortality rate and an insect control rate were calculated using the numerical equations shown below. Insect mortality rate (%) = {(Number of dead insects) / (Number of insects in sample)} x 100 Control rate = {1 - (Nt) / (Nc)} x 100 where Nt: number of parasites in the area treated with the spray; and Nc: number of parasites in the untreated area (Example of Trial 1) Efficacy Trial against Mythimna separata 0.8 g of a commercially available artificial feed (Insecta LFS, manufactured by Nosan Corporation) and 1 μA of Emulsion (I) were vigorously mixed, and 0.2 g of the resulting mixture was placed in each of the treatment areas of a plastic test container (volume: 1.4 ml) to complete the preparation of a test feed. Two second-instar larvae of Mythimna separata were inoculated into each treatment area, and the test container was hermetically sealed with a plastic lid. The hermetically sealed container was placed in a thermostatic chamber at 25°C, and the insect mortality rate and the amount of food consumed on the fifth day were determined. The test was performed twice. Additionally, a control trial was conducted under the same conditions as those described above, except for the exclusion of the compound of the present invention from the Emulsion (I) mentioned above. Efficacy trials against Mythimna separata were conducted for the compounds shown in Table 3. For all compounds, the mortality rate against Mythimna separata was 100%, or the amount of food consumed was 10% or less than the amount of food consumed in the control. Table 3 1-1 1-16 1-38 1-50 1-2 1-17 1-39 1-51 1-3 1-19 1-40 1-52 1-4 1-23 1-41 1-55 1-5 1-27 1-42 1-56 1-6 1-30 1-43 1-7 1-31 1-44 1-8 1-33 1-45 1-9 1-35 1-46 1-13 1-15 1-36 1-37 1-47 1-48 (Example of Trial 2) Efficacy trial against Spodoptera litura The emulsion (I) was diluted with water to achieve a concentration of 125 ppm of the compound of the present invention. Cabbage leaves were soaked in the diluted liquid for 30 seconds. The leaves were then placed on Petri dishes and inoculated with 5 second-instar larvae of Spodoptera litura. The Petri dishes were placed in a thermostatic chamber at 25°C and 60% humidity. Mortality was assessed 6 days after inoculation, and the insect mortality rate was calculated. The test was performed twice. The efficacy trial against Spodoptera litura was carried out for the compounds shown in Table 4. All compounds demonstrated an 80% or higher insect mortality rate against Spodoptera litura. Table 4 1-4 1-37 1-43 1-54 1-5 1-40 1-46 1-6 1-41 1-47 1-35 1-42 1-51 (Example of Trial 3) Efficacy trial against Plutella xylostella The emulsion (I) was diluted with water to achieve a concentration of 125 ppm of the compound of the present invention. Cabbage leaves were soaked in the diluted liquid for 30 seconds. The leaves were then placed on Petri dishes and inoculated with 5 second-instar larvae of Plutella xylostella. The Petri dishes were placed in a thermostatic chamber at 25°C and 60% humidity. Mortality was assessed 3 days after inoculation, and the insect mortality rate was calculated. The experiment was performed twice. The efficacy trial against Plutella xylostella was conducted for the compounds shown in Table 5. All compounds demonstrated a mortality rate of 80% or higher against Plutella xylostella. Table 5 1-1 1-19 1-40 1-51 1-2 1-23 1-41 1-52 1-3 1-27 1-42 1-54 1-4 1-30 1-43 1-55 1-5 1-33 1-46 1-6 1-35 1-47 1-9 1-36 1-48 1-13 1-37 1-49 1-17 1-39 1-50 (Example trial 4) Efficacy trial against Aphis gossypii The emulsion (I) was diluted with water so that the concentration of the compound of the present invention was 125 ppm. Cucumbers were grown in No. 3 containers, and the first leaves were inoculated with Aphis gossypii nymphs. The aforementioned diluted emulsion was sprayed onto the cucumber seedlings. The cucumber seedlings were then placed in a thermostatic chamber at 25°C and 60% humidity. Mortality was investigated 4 days after spraying, and the mortality rate of the Aphis gossypii insects was calculated. The trial was carried out twice. The efficacy trial against Aphis gossypii was conducted for the compounds according to the compound numbers shown in Table 6. All compounds demonstrated a mortality rate of 80% or higher against Aphis gossypii. Table 6 1-1 I 1-2 I 1-3 I 1-4 (Example trial 5) Efficacy trial against Aphis craccivora Black-eyed pea plants were grown in No. 3 containers, and the first leaves were inoculated with Aphis craccivora nymphs. Emulsion (I) was diluted with water to a concentration of 125 ppm. The diluted liquid was then sprayed onto the black-eyed pea plants, which were infested with Aphis craccivora nymphs. The plants were then placed in a thermostatic chamber at 25°C and 60% humidity. Mortality was measured four days after spraying, and the mortality rate of the Aphis craccivora insects was calculated. The trial was performed twice. The efficacy trial against Aphis craccivora was carried out for the compounds shown in Table 7. All compounds demonstrated a mortality rate of 80% or higher against Aphis craccivora. Table 7 1-1 1-2 1-3 1-13

Claims

1. A compound represented by Formula (I) or a salt thereof, excluding its therapeutic application in humans, FOLLOWS FORMULA 1, characterized in that each of R1 and R2 independently represents a hydrogen atom, a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 3- to 6-membered heterocyclyl group, provided that if R2 is a hydrogen atom, R1 is a substituted or unsubstituted C6-10 aryl group or a substituted or unsubstituted 3- to 6-membered heterocyclyl group, and if R1 represents a hydrogen atom, R2 represents a substituted or unsubstituted C6-10 aryl group or a substituted or unsubstituted 3- to 6-membered heterocyclyl group, wherein the substituted group of the “C6-10 aryl” group or the “3- to 6-membered heterocyclyl group” of R 1 and R 2 is a halogen group, a C1-6 alkyl group, a C1-6 haloalkyl group, a C1-6 haloalkoxy group, an amino group, a C1-6 monoalkoxy carbonylamino group,a cyano group or an oxo group, R3 represents a C1-6 sulfonyl alkyl group, R4 represents a C1-6 alkyl group or a substituted or unsubstituted amino group, wherein the substituted amino group of R4 is a C1-6 alkyl amino group, a C3-8 cyanoalkyl amino group, a C1-6 carbonylamino alkyl group, a mono(C1-6 carbonyl alkoxy)amino group, or a di(C1-6 carbonyl alkoxy)amino group, R5 represents a hydrogen atom, and Ar represents a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heteroaryl group, wherein the substituted group of the “C6-10 aryl group” and of the “5- to 6-membered heteroaryl group” of AR is a C1-6 haloalkyl group, a C1-6 haloalkoxy group, or a C1-6 haloalkyl group. thio or a C1-6 haloalkyl sulfonyl group. Four claims follow,